<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7914888</article-id><article-id pub-id-type="pmid">33562431</article-id><article-id pub-id-type="doi">10.3390/ijms22041591</article-id><article-id pub-id-type="publisher-id">ijms-22-01591</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Reciprocal Changes in miRNA Expression with Pigmentation and Decreased Proliferation Induced in Mouse B16F1 Melanoma Cells by <sc>l</sc>-Tyrosine and 5-Bromo-2&#x02032;-Deoxyuridine</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8901-4059</contrib-id><name><surname>Rivera</surname><given-names>Hern&#x000e1;n Mauricio</given-names></name><xref ref-type="aff" rid="af1-ijms-22-01591">1</xref><xref ref-type="aff" rid="af2-ijms-22-01591">2</xref></contrib><contrib contrib-type="author"><name><surname>Mu&#x000f1;oz</surname><given-names>Esther Natalia</given-names></name><xref ref-type="aff" rid="af1-ijms-22-01591">1</xref><xref ref-type="aff" rid="af2-ijms-22-01591">2</xref></contrib><contrib contrib-type="author"><name><surname>Osuna</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="af3-ijms-22-01591">3</xref></contrib><contrib contrib-type="author"><name><surname>Florez</surname><given-names>Mauro</given-names></name><xref ref-type="aff" rid="af3-ijms-22-01591">3</xref></contrib><contrib contrib-type="author"><name><surname>Carvajal</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="af3-ijms-22-01591">3</xref></contrib><contrib contrib-type="author"><name><surname>G&#x000f3;mez</surname><given-names>Luis Alberto</given-names></name><xref ref-type="aff" rid="af2-ijms-22-01591">2</xref><xref ref-type="aff" rid="af4-ijms-22-01591">4</xref><xref rid="c1-ijms-22-01591" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-ijms-22-01591"><label>1</label>Department of Medicine, Universidad Nacional de Colombia, Bogot&#x000e1; 111321, Colombia; <email>hmriverae@unal.edu.co</email> (H.M.R.); <email>enmunozro@unal.edu.co</email> (E.N.M.)</aff><aff id="af2-ijms-22-01591"><label>2</label>Molecular Physiology Group, Sub-Direction of Scientific and Technological Research, Direction of Public Health Research, National Institute of Health, Bogot&#x000e1; 111321, Colombia</aff><aff id="af3-ijms-22-01591"><label>3</label>Science Department, Universidad Nacional de Colombia, Bogot&#x000e1; 111321, Colombia; <email>daosunag@unal.edu.co</email> (D.O.); <email>maeflorezro@unal.edu.co</email> (M.F.); <email>mscarvajalp@unal.edu.co</email> (M.C.)</aff><aff id="af4-ijms-22-01591"><label>4</label>Department of Physiological Sciences, Faculty of Medicine, Universidad Nacional de Colombia, Bogot&#x000e1; 111321, Colombia</aff><author-notes><corresp id="c1-ijms-22-01591"><label>*</label>Correspondence: <email>lgomez@ins.gov.co</email></corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>2</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2021</year></pub-date><volume>22</volume><issue>4</issue><elocation-id>1591</elocation-id><history><date date-type="received"><day>01</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>03</day><month>1</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 by the authors.</copyright-statement><copyright-year>2021</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><italic>Background</italic>: Many microRNAs have been identified as critical mediators in the progression of melanoma through its regulation of genes involved in different cellular processes such as melanogenesis, cell cycle control, and senescence. However, microRNAs&#x02019; concurrent participation in syngeneic mouse B16F1 melanoma cells simultaneously induced decreased proliferation and differential pigmentation by exposure to 5-Brd-2&#x02032;-dU (5&#x02019;Bromo-2-deoxyuridine) and L-Tyr (L-Tyrosine) respectively, is poorly understood. <italic>Aim</italic>: To evaluate changes in the expression of microRNAs and identify which miRNAs in-network may contribute to the functional bases of phenotypes of differential pigmentation and reduction of proliferation in B16F1 melanoma cells exposed to 5-Brd-2&#x02032;-dU and L-Tyr. <italic>Methods</italic>: Small RNAseq evaluation of the expression profiles of miRNAs in B16F1 melanoma cells exposed to 5-Brd-2&#x02032;-dU (2.5 &#x003bc;g/mL) and L-Tyr (5 mM), as well as the expression by qRT-PCR of some molecular targets related to melanogenesis, cell cycle, and senescence. By bioinformatic analysis, we constructed network models of regulation and co-expression of microRNAs. <italic>Results</italic>: We confirmed that stimulation or repression of melanogenesis with L-Tyr or 5-Brd-2&#x02032;-dU, respectively, generated changes in melanin concentration, reduction in proliferation, and changes in expression of microRNAs 470-3p, 470-5p, 30d-5p, 129-5p, 148b-3p, 27b-3p, and 211-5p, which presented patterns of coordinated and reciprocal co-expression, related to changes in melanogenesis through their putative targets <italic>Mitf</italic>, <italic>Tyr</italic> and <italic>Tyrp1</italic>, and control of cell cycle and senescence: <italic>Cyclin D1</italic>, <italic>Cdk2</italic>, <italic>Cdk4</italic>, <italic>p21</italic>, and <italic>p27</italic>. <italic>Conclusions</italic>: These findings provide insights into the molecular biology of melanoma of the way miRNAs are coordinated and reciprocal expression that may operate in a network as molecular bases for understanding changes in pigmentation and decreased proliferation induced in B16F1 melanoma cells exposed to L-Tyr and 5-Brd-2&#x02032;-dU.</p></abstract><kwd-group><kwd>melanoma</kwd><kwd>miRNAs</kwd><kwd>l-tyrosine</kwd><kwd>5-bromo-2&#x02032;-deoxyuridine</kwd><kwd>melanin</kwd><kwd>senescence</kwd><kwd>pigmentation</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-ijms-22-01591"><title>1. Introduction</title><p>Many transcripts show hundreds of genes change in expression in melanoma progression. These changes involve genetic and epigenetic mechanisms, such as mutations, gene silencing of tumor suppressors through DNA methylation in promoter regions, oncogene activation, chromatin remodeling, and regulation mediated by non-coding RNAs, such as microRNAs (miRNAs) through their regulation of genes involved in different cellular processes such as proliferation, death, cycle control, senescence, angiogenesis, differentiation, and even metastasis [<xref rid="B1-ijms-22-01591" ref-type="bibr">1</xref>,<xref rid="B2-ijms-22-01591" ref-type="bibr">2</xref>,<xref rid="B3-ijms-22-01591" ref-type="bibr">3</xref>,<xref rid="B4-ijms-22-01591" ref-type="bibr">4</xref>,<xref rid="B5-ijms-22-01591" ref-type="bibr">5</xref>,<xref rid="B6-ijms-22-01591" ref-type="bibr">6</xref>,<xref rid="B7-ijms-22-01591" ref-type="bibr">7</xref>,<xref rid="B8-ijms-22-01591" ref-type="bibr">8</xref>]. miRNA can have hundreds of mRNAs as molecular targets. One mRNA can target several miRNAs, and the researchers will identify variations in the expression of thousands of genes that may result from changes in some miRNAs&#x02019; expression patterns [<xref rid="B9-ijms-22-01591" ref-type="bibr">9</xref>,<xref rid="B10-ijms-22-01591" ref-type="bibr">10</xref>,<xref rid="B11-ijms-22-01591" ref-type="bibr">11</xref>,<xref rid="B12-ijms-22-01591" ref-type="bibr">12</xref>,<xref rid="B13-ijms-22-01591" ref-type="bibr">13</xref>].</p><p>Previous works on the mouse melanoma B16F1 cell line showed that 72-h exposure to 5 mM L-Tyr resulted in increased cell size and pigmentation, while exposure to 5-Brd-2&#x02032;-dU 2.5 &#x000b5;g/mL showed cells with a senescence-associated phenotype and hypopigmentation; however, a decrease in cell growth was reported [<xref rid="B14-ijms-22-01591" ref-type="bibr">14</xref>,<xref rid="B15-ijms-22-01591" ref-type="bibr">15</xref>]. These changes coincide with the differential expression of hundreds of genes evaluated in this experimental model, including cyclins, cyclin-dependent kinases (CDKs), and CDKs inhibitors [<xref rid="B16-ijms-22-01591" ref-type="bibr">16</xref>,<xref rid="B17-ijms-22-01591" ref-type="bibr">17</xref>]. In 2008, it was possible to identify two miRNAs (miR-138-5p and miR-470-3p) that presented differential expression, which had <italic>cyclin D1</italic> as a molecular target [<xref rid="B18-ijms-22-01591" ref-type="bibr">18</xref>]. However, the differential expression profile of miRNAs for this experimental model is unknown, as well as their possible coordinated and altered expression, evidence that could to expand our knowledge about melanoma plasticity is seen from the microRNAs post-transcriptional regulation mechanisms, and at least in part, to explain the changes in gene expression previously reported for this model of proliferation reduction and differential pigmentation.</p><p>Our objective was to assess miRNA expression changes and examine whether a coordinated expression of miRNAs and their potential targets are associated with the differential pigmentation and reduction of proliferation in B16F1 melanoma cells exposed to 5-Brd-2&#x02032;-dU and L-Tyr. This work contributes to the knowledge about specific microRNA profiles in B16 melanoma cells under growth suppression and differential pigmentation. L-Tyr and 5-Brd-2&#x02032;-dU induced coordinated expression on potential molecular targets and enhance the hypothesis of microRNAs that affect cellular programs by exerting control over different genes.</p></sec><sec sec-type="results" id="sec2-ijms-22-01591"><title>2. Results</title><sec id="sec2dot1-ijms-22-01591"><title>2.1. Decreased Proliferation and Pigmentation Changes in Melanoma B16F1 Cells</title><p>The MTT assay and the exclusion of Trypan Blue revealed a reduction in cell B16F1 melanoma cells. Decrease in viable cells (to less than 50%) secondary to 72 h-long treatment with 5.0 mM amino acid L-Tyrosine (L-Tyr) (<italic>n</italic> = 3) or 2.5 &#x003bc;g/mL thymidine analog 5-Bromo-2&#x02032; deoxyuridine (5-Brd-2&#x02032;-dU) (<italic>n</italic> = 3); in both cases, exposure for 72 h to L-Tyr and 5-Brd-2&#x02032;-dU generated a statistically significant decrease in the number of B16F1 cells, from 3.6 &#x000d7; 10<sup>6</sup> &#x000b1; 1.16 &#x000d7; 10<sup>5</sup> to 7.4 &#x000d7; 10<sup>5</sup> &#x000b1; 9.23 &#x000d7; 10<sup>4</sup> (79% reduction) and 1.3 &#x000d7; 10<sup>6</sup> &#x000b1; 5.5 &#x000d7; 10<sup>4</sup> (64% reduction), respectively (<xref ref-type="fig" rid="ijms-22-01591-f001">Figure 1</xref>b; <xref ref-type="app" rid="app1-ijms-22-01591">Figure S1c</xref>). Cells exposed to 5-Brd-2&#x02032;-dU showed more expanded and flattened forms, while cells exposed to L-Tyr presented morphology similar to that of melanocytes with the presence of longer dendritic processes (<xref ref-type="fig" rid="ijms-22-01591-f001">Figure 1</xref>a). We observed these changes over time (240 h) (<xref ref-type="app" rid="app1-ijms-22-01591">Figure S1a</xref>). Morphological changes and cell proliferation changes had already been reported previously for exposure to L-Tyr [<xref rid="B19-ijms-22-01591" ref-type="bibr">19</xref>,<xref rid="B20-ijms-22-01591" ref-type="bibr">20</xref>] and 5-Brd-2&#x02032;-dU [<xref rid="B21-ijms-22-01591" ref-type="bibr">21</xref>,<xref rid="B22-ijms-22-01591" ref-type="bibr">22</xref>], although there were variations in exposure concentrations.</p><p>Reduction in cell number was associated with death. The number of cells in supernatants by I.P. incorporation; in unexposed cells (Control), the value was 1.1 &#x000d7; 10<sup>4</sup> &#x000b1; 1.1 &#x000d7; 10<sup>3</sup>, while for L-Tyr exposure, it was 2.9 &#x000d7; 10<sup>4</sup> &#x000b1; 4.8 &#x000d7; 10<sup>3</sup>. For 5-Brd-2&#x02032;-dU, it was 5.1 &#x000d7; 10<sup>4</sup> &#x000b1; 1.1 &#x000d7; 10<sup>4</sup>. The values obtained in supernatants were on average (97 X) and (45 X) lower than the differences found by trypan blue in unexposed B16F1 cells (Control) and its counterpart, cells exposed to L-Tyr and 5-Brd-2&#x02032;-dU. The above suggests that other mechanisms may explain the reduction of cells; therefore, we calculated the population doubling times from the MTT reductase activity assay and its corresponding calibration curve (<xref ref-type="fig" rid="ijms-22-01591-f001">Figure 1</xref>d; <xref ref-type="app" rid="app1-ijms-22-01591">Figure S1b,c</xref>). The population doubling times increased from 19.6 &#x000b1; 3.94 h (CV, coefficient of variation of 20%) to 48.67 &#x000b1; 6.25 h (CV of 13%) and 27.03 &#x000b1; 3.0 h (CV of 11%) for exposure to L-Tyr and 5-Brd-2&#x02032;-dU, respectively. These differences indicated that reducing the number of cells at 72 h would be the consequence of variations in the cell cycle control.</p><p>Cell cycle analysis (<xref ref-type="fig" rid="ijms-22-01591-f001">Figure 1</xref>e) showed changes in the DNA content of cells exposed to L-Tyr and 5-Brd-2&#x02032;-dU. Indeed; statistically, significant changes occurred in the transition of the G0/G1 phase (from 50 &#x000b1; 3.0% to 66.6 &#x000b1; 2.8%) and G2/M (from 15.7 &#x000b1; 1.6% to 2.4 &#x000b1; 1.2%) for 5-Brd-2&#x02032;-dU and in the S phase for L-Tyr (from 24.4 &#x000b1; 0.7% to 15.8 &#x000b1; 3.6%). The cells exposed to L-Tyr significantly increased in the G0/G1 phase (55.5 &#x000b1; 3.8%, <italic>n</italic> = 3).</p><p>Based on the method described [<xref rid="B23-ijms-22-01591" ref-type="bibr">23</xref>,<xref rid="B24-ijms-22-01591" ref-type="bibr">24</xref>], we quantified the formation of melanin pigment in culture B16F1 melanoma cells under standardized conditions [<xref rid="B15-ijms-22-01591" ref-type="bibr">15</xref>,<xref rid="B25-ijms-22-01591" ref-type="bibr">25</xref>] and 5-Brd-2&#x02032;-dU [<xref rid="B14-ijms-22-01591" ref-type="bibr">14</xref>,<xref rid="B21-ijms-22-01591" ref-type="bibr">21</xref>,<xref rid="B26-ijms-22-01591" ref-type="bibr">26</xref>]. Synthetic melanin helped construct calibration curves to quantify by spectrophotometry and fluorometry (<xref ref-type="app" rid="app1-ijms-22-01591">Figure S1d</xref>). The quantification of melanin by both methods was comparable (<xref ref-type="fig" rid="ijms-22-01591-f001">Figure 1</xref>b) (Pearson&#x02019;s correlation coefficient 0.999). The two approaches allowed the detection of increase (9 X) and decrease (5 X) in melanin concentration in B16 cells exposed to L-Tyr and 5-Brd-2&#x02032;-dU, respectively (<xref ref-type="fig" rid="ijms-22-01591-f001">Figure 1</xref>f). However, fluorometry was more sensitive (detection limit 0.098 &#x003bc;g/mL and CV of 9.85%). Up to this point, the pooled results confirmed that exposure to L-Tyr and 5-Brd-2&#x02032;-dU induces an arrest at different points in the cell cycle control for B16F1 cells and differential pigmentation phenotype that could be associated with changes in the expression of genes involved in melanin synthesis.</p></sec><sec id="sec2dot2-ijms-22-01591"><title>2.2. Induction of Replicative Senescence in B16F1 Cells Exposed to 5-Brd-2&#x02032;-dU</title><p>5-Brd-2&#x02032;-dU induced replicative senescence, a phenotype described in different cell models [<xref rid="B27-ijms-22-01591" ref-type="bibr">27</xref>,<xref rid="B28-ijms-22-01591" ref-type="bibr">28</xref>,<xref rid="B29-ijms-22-01591" ref-type="bibr">29</xref>], including B16 cells [<xref rid="B30-ijms-22-01591" ref-type="bibr">30</xref>,<xref rid="B31-ijms-22-01591" ref-type="bibr">31</xref>]. We confirmed by Senescence-associated beta-galactosidase (S.A. &#x003b2;-Gal) assay, histone H3K9me3 labeling, apparent cell area measurement and flow cytometry, size analysis (FSC), and complexity (SSC) (<xref ref-type="fig" rid="ijms-22-01591-f002">Figure 2</xref>). Although not all cells were positive at pH 6.0 (<xref ref-type="fig" rid="ijms-22-01591-f002">Figure 2</xref>a), the chromogenic S.A. &#x003b2;-Gal assay revealed a significant increase (3.7 X) in the number of cells positive to the substrate X-Gal by exposure to 5-Brd-2&#x02032;-dU against control or those exposed to L-Tyr (<xref ref-type="fig" rid="ijms-22-01591-f002">Figure 2</xref>b). </p><p>The histone H3K9me3 associated with heterochromatin&#x02019;s remodeling ([<xref rid="B31-ijms-22-01591" ref-type="bibr">31</xref>,<xref rid="B32-ijms-22-01591" ref-type="bibr">32</xref>] increased in cells exposed to 5-Brd-2&#x02032;-dU revealed by higher fluorescence intensity. The number of concentrated foci, which is associated with heterochromatin (SAHF) [<xref rid="B32-ijms-22-01591" ref-type="bibr">32</xref>], some of these SAHF, coincides with a greater density obtained by DAPI labeling (<xref ref-type="fig" rid="ijms-22-01591-f002">Figure 2</xref>c).</p><p>Although the cells exposed to both stimuli showed greater apparent cell area (2.6 &#x000d7; 10<sup>&#x02212;2</sup> mm<sup>2</sup> for L-Tyr and 3.3 &#x000d7; 10<sup>&#x02212;2</sup> mm<sup>2</sup> for 5-Brd-2&#x02032;-dU) compared to the control (1.5 &#x000d7; 10<sup>&#x02212;2</sup> mm<sup>2</sup>) (<xref ref-type="fig" rid="ijms-22-01591-f002">Figure 2</xref>d); cells with 5-Brd-2&#x02032;-dU changed in size (FSC, quadrant Q3) going from 3.8% to 9.7%. These cells also had higher metabolic activity measured by MTT reductase assay (<xref ref-type="app" rid="app1-ijms-22-01591">Figure S1d</xref>), where the slope of the calibration curve was 1.39 compared to 1.22 for the control. Overall, the results of exposure to 5-Brd-2&#x02032;-dU suggest a phenotype associated with senescence and agree with that previously reported in 5-Brd-2&#x02032;-dU-induced senescence models, where an increase in lysosomal organelles would explain the more significant S.A. &#x003b2;-Gal activity and increase in messenger RNA [<xref rid="B33-ijms-22-01591" ref-type="bibr">33</xref>,<xref rid="B34-ijms-22-01591" ref-type="bibr">34</xref>,<xref rid="B35-ijms-22-01591" ref-type="bibr">35</xref>]. Exposure to L-Tyr, the cells increased both in complexity (SSC) and in size (quadrants Q1 and Q2), going from 5.4 and 3.3% in the control cells to 26.7 and 20.8%, respectively (<xref ref-type="fig" rid="ijms-22-01591-f002">Figure 2</xref>e).</p></sec><sec id="sec2dot3-ijms-22-01591"><title>2.3. Small RNAseq and Differential Expression Analysis of miRNAs</title><p>The alteration of different cellular programs in melanoma, control of the cell cycle, pigmentation, and senescence are associated with changes in the expression of miRNAs and their effect on the post-transcriptional regulation of target genes [<xref rid="B11-ijms-22-01591" ref-type="bibr">11</xref>,<xref rid="B36-ijms-22-01591" ref-type="bibr">36</xref>]. For the phenotypes induced in B16F1 cells, exposure to L-Tyr or 5-Brd-2&#x02032;-dU causes changes in hundreds of genes [<xref rid="B14-ijms-22-01591" ref-type="bibr">14</xref>,<xref rid="B31-ijms-22-01591" ref-type="bibr">31</xref>,<xref rid="B37-ijms-22-01591" ref-type="bibr">37</xref>]. However, it is unknown whether there are differences in the expression of miRNAs in these phenotypes. For this reason, we proceeded to identify and quantify by small RNAseq the expression of miRNAs in cells exposed to 5-Brd-2&#x02032;-dU and L-Tyr (<xref ref-type="app" rid="app1-ijms-22-01591">Figure S2</xref>) and establish the differences in expression concerning non-exposed cells (<xref ref-type="fig" rid="ijms-22-01591-f003">Figure 3</xref>).</p><p>The quality and integrity number (RIN) of the extracted RNA was within the values required for the Small RNAseq (<xref ref-type="app" rid="app1-ijms-22-01591">Figure S2a</xref>). The average of readings obtained after sequencing for each experimental group (<italic>n</italic> = 3) was 1.38 &#x000d7; 10<sup>7</sup>, 8.0 &#x000d7; 10<sup>6</sup>, and 1.03 &#x000d7; 10<sup>7</sup> for control cells, exposed to L-Tyr or 5-Brd-2&#x02032;-dU, respectively (<xref ref-type="app" rid="app1-ijms-22-01591">Figure S2b</xref>); these readings presented Phred score values close to 40, indicating a 99.99% precision in the database call (data not shown, obtained by FastQC). With the readings, we constructed an expression matrix that contained in each row the identification number (I.D.) of the mature miRNA for sequences that presented 100% agreement with the sequences reported in miRBase version 21. We listed on each column the total number of counts for each miRNA. The principal component analysis (PCA) showed greater homogeneity in the control samples and a more significant variation in those exposed to 5-Brd-2&#x02032;-dU. When running DESEq2 on the expression matrix&#x02019;s normalized data, some miRNAs changed, measured as the Log<sub>2</sub> Fold Change, which suggests differential expression (M.A. plot of <xref ref-type="app" rid="app1-ijms-22-01591">Figure S2d,e</xref>), some of them, when correcting multiple tests, maintained their statistical significance (<xref rid="ijms-22-01591-t001" ref-type="table">Table 1</xref>). In cells exposed to L-Tyr, 35, 21 were under-expressed, and 14 over-expressed. In cells exposed to 5-Brd-2&#x02032;-dU, the number of miRNAs with differential expression was 32, 11 of them under-expressed, and 21 over-expressed, all concerning control B16F1 cells (<xref rid="ijms-22-01591-t001" ref-type="table">Table 1</xref>).</p><p>Similarities and differences in the expression of the miRNAs obtained in cells exposed to L-Tyr or 5-Brd-2&#x02032;-dU concerning the control were shown with heat maps. We exclusively included the list of differentially expressed miRNAs (<xref ref-type="fig" rid="ijms-22-01591-f003">Figure 3</xref>a; <xref ref-type="app" rid="app1-ijms-22-01591">Figure S2g,h</xref>). As shown in <xref ref-type="fig" rid="ijms-22-01591-f003">Figure 3</xref>a the patterns obtained were common in overexpression for miR-30d-5p, miR-129-5p, miR-99b-5p, and miR-191-5p and of under-expression for members of the <italic>let</italic>-7 family (a-5p, d-5p), and the miRNAs, miR-23a-3p and miR-361-5p. The miR-211-5p was the only miRNA that presented overexpression in cells exposed to L-Tyr and under-expression with 5-Brd-2&#x02032;-dU. However, the comparison of miRNAs differentially expressed in cells exposed to 5-Brd-2&#x02032;-dU concerning L-Tyr yielded another set of miRNAs with orders in differential expression not visualized under the previous comparison exposure model the control (<xref rid="ijms-22-01591-t001" ref-type="table">Table 1</xref> and <xref ref-type="app" rid="app1-ijms-22-01591">Figure S2f,i</xref>). Since this case&#x02019;s expression level was not the same, the exposure to L-Tyr or 5-Brd-2&#x02032;-dU may generate changes in some miRNAs&#x02019; expression in a differential way. (<xref ref-type="app" rid="app1-ijms-22-01591">Figure S2i</xref>). Overall, the miRNAs&#x02019; expression revealed a different expression profile in B16 cells in response to exposure to L-Tyr or 5-Brd-2&#x02032;-dU. This profile was related to the observed differential pigmentation, proliferation, and senescence changes induced in this cellular model.</p></sec><sec id="sec2dot4-ijms-22-01591"><title>2.4. Confirmation of miRNAs Differential Expression by RT-qPCR Stem-Loop and Prediction of miRNA Targets Associated with Induced Phenotypes</title><p>We confirmed in terms relative differential expressions (rER) the expression of 7 miRNAs reported in <xref rid="ijms-22-01591-t001" ref-type="table">Table 1</xref> (211-5p, 30d-5p, 148b-3p, 129-5p, 27b-3p, 470-3p and 470-5p) by RT-qPCR stem-loop (<xref ref-type="fig" rid="ijms-22-01591-f004">Figure 4</xref>) (<italic>n</italic> = 3). miR-211-5p, increased 2.5 X by exposure to L-Tyr and a decreased 2 X, for 5-Brd-2&#x02032;-dU (<xref ref-type="fig" rid="ijms-22-01591-f004">Figure 4</xref>a; <xref rid="ijms-22-01591-t001" ref-type="table">Table 1</xref>). On the other hand, the overexpression of miR-30d-5p, increased by 5.4 X and 8 X (<xref ref-type="fig" rid="ijms-22-01591-f004">Figure 4</xref>c; <xref rid="ijms-22-01591-t001" ref-type="table">Table 1</xref>) and of miR-129-5p, increased by 4.5 X and 1.4 X (<xref ref-type="fig" rid="ijms-22-01591-f004">Figure 4</xref>c; <xref rid="ijms-22-01591-t001" ref-type="table">Table 1</xref>) for exposure to L-Tyr and 5-Brd-2&#x02032;-dU, respectively (<xref ref-type="fig" rid="ijms-22-01591-f004">Figure 4</xref>c; <xref rid="ijms-22-01591-t001" ref-type="table">Table 1</xref>). RT-qPCR found miR-27b-3p, miR-148b-3p, a differentially expressed with values that did not agree in trend to those reported in <xref rid="ijms-22-01591-t001" ref-type="table">Table 1</xref> in DESEq2. Compared to the reduction registered by small RNAseq due to exposure to L-Tyr (miR-27b-3p 1.5 X and miR-148b-3p 2.0 X), by qPCR, both miRNAs increased their expression concerning the control (3.1 X and 4.5 X) respectively (<xref ref-type="fig" rid="ijms-22-01591-f004">Figure 4</xref>c; <xref rid="ijms-22-01591-t001" ref-type="table">Table 1</xref>). For exposure to 5-Brd-2&#x02032;-dU, we found an increase (3.3 X and 3.55 X) in expression by qPCR.</p><p>miRNAs showed common and coordinated expression patterns in this differential pigmentation and reduced proliferation induced in melanoma B16F1 cells. We identified potential targets of miRNAs by prediction with TargetScanMouse (<xref ref-type="fig" rid="ijms-22-01591-f004">Figure 4</xref>a&#x02013;c). Some genes participated in controlling the cell cycle and senescence (i.e., <italic>Ccnd1</italic>, <italic>Cdk2</italic>, <italic>Cdk4</italic>, and <italic>p21</italic>/<italic>Cdkn1a</italic>, <italic>Rb1</italic>, <italic>E2F2</italic>, <italic>Atm</italic>, <italic>Foxm1</italic>, and <italic>E2F3</italic>). Other targets (i.e., <italic>Mitf</italic>, <italic>Tyr</italic>, <italic>Tyrp1</italic>, or <italic>Dct</italic>) were involved in melanin synthesis. miRNAs presented changes in their expression and targeted genes associated with controlling the cell cycle and senescence as expected (<xref ref-type="fig" rid="ijms-22-01591-f004">Figure 4</xref>a, <xref rid="ijms-22-01591-t001" ref-type="table">Table 1</xref>).</p></sec><sec id="sec2dot5-ijms-22-01591"><title>2.5. Regulatory Networks and Co-Expression Networks (RC-miR)</title><p>The miRNAs are associated with melanoma&#x02019;s cellular processes independently; however, we intend to relate the effect they would have together and their potential molecular targets on the phenotype induced by L-Tyr y 5-Brd-2&#x02032;-dU. We constructed possible gene interaction networks using the miRNet web application with the differentially expressed miRNAs, their putative genes, and functional enrichment analysis by KEGG signaling pathways (<xref ref-type="fig" rid="ijms-22-01591-f003">Figure 3</xref>b&#x02013;d, <xref ref-type="app" rid="app1-ijms-22-01591">Tables S1&#x02013;S3</xref> Functional Enrichment using KEGG).</p><p>In cells exposed to L-Tyr, enrichment revealed a total of 269 KEGG pathways, 2641 hits, and 1458 nodes; of which, 36 routes with 828 hits passed the hypergeometric test (<xref ref-type="fig" rid="ijms-22-01591-f003">Figure 3</xref>b). In cells exposed to 5-Brd-2&#x02032;-dU, 256 KEGG pathways, 1560 hits, and 962 nodes; 11 routes and 169 hits with statistical significance (<xref ref-type="fig" rid="ijms-22-01591-f003">Figure 3</xref>c). Of these pathways, the regulation of proliferation, apoptosis, differentiation, survival, and pathways associated with cellular metabolism related to the phenotype induced by exposure to L-Tyr; while the p53, FoxO, apoptosis, Jak-STAT, and altered transcriptional regulation in cancer pathways related to the phenotype caused by exposure to 5-Brd-2&#x02032;-dU.</p><p>We reviewed the gene regulation network constructed for the miRNAs differentially expressed in cells exposed to 5-Brd-2&#x02032;-dU concerning L-Tyr. The network contained a total of 255 KEGG routes, 1671 hits, and 903 nodes; of which, 21 routes with 337 hits passed the hypergeometric test (<xref ref-type="fig" rid="ijms-22-01591-f003">Figure 3</xref>d). In this case, we observed other pathways involved, such as cell cycle, Wnt, and ubiquitin-mediated proteolysis. The data reported so far show the existence of a specific miRNA expression profile for each induced phenotype. This profile, seen from a network gene regulation model, would be associated with controlling different cellular programs through their target genes.</p><p>We used mutual information to measure similarity and co-expression networks (RC-miR) based on adjacency matrices for the differentially expressed miRNAs. As can be seen in <xref ref-type="fig" rid="ijms-22-01591-f004">Figure 4</xref>d, in cells exposed to 5-Brd-2&#x02032;-dU, 9 clusters of miRNAs were identified, two of them over-expressed (miR-129-3p, miR-99b-5p, miR-378-3p, and miR-30d-5p) and (miR-129-5p, miR-21a-5p, and miR-335-3p), which according to TargetScan would have as a common target the factor <italic>E2F2</italic>; the cluster miR-455-3p, miR-29c-3p and miR-335-5p on <italic>p21</italic> and the cluster miR-29c-3p and let-7e-5p on <italic>Ccnd1</italic> (<xref ref-type="fig" rid="ijms-22-01591-f004">Figure 4</xref>a). While for under-expressed miRNAs, we found the cluster let-7a-5p and let-7b-5p that would have as a putative target <italic>Tyr</italic>, <italic>Ccnd1</italic>, <italic>Cdk4</italic>, <italic>E2F2</italic>, <italic>E2F3</italic>, and <italic>Rb1</italic>.</p><p>In cells exposed to L-Tyr, 10 sets were found, of which, it was coincident with 5-Brd-2&#x02032;-dU, finding over-expressed miR-129-3p, miR-99b-5p, and miR-30d-5p and miR-211-3p, miR-149-5p and miR-129-5p clusters as a possible target of <italic>p21</italic>. We found two clusters of potential regulators for <italic>Ccnd1</italic>: one with over-expressed miRNAs (miR-149-5p and miR-129-5p) and one under-expressed (miR-320-3p and miR-23b-3p), which could imply a coordinated regulation by expression to the high and low of the whole set of miRNAs. Regarding sets of under-expressed miRNAs, we found a cluster with the <italic>let</italic>-7 family (a, c, d) and the miR-151-5p, whose potential target was <italic>E2F2</italic>.</p></sec><sec id="sec2dot6-ijms-22-01591"><title>2.6. Analysis of Differential Expression mRNAs and Protein Level</title><p>The mRNA expression levels of the selected genes were quantified by RT-qPCR, which we reported as the relative of differential expression (rER) concerning the housekeeping gene GAPDH and B16F1 cells. Western blot and immunofluorescence determined the expression and location of the corresponding protein. We evaluated some mRNAs involved in the cell cycle and senescence: Cyclin D1 (Ccdn1) expression, cyclin-dependent kinases Cdk4 and Cdk2, and the cyclin-dependent kinase inhibitor p21 (<xref ref-type="fig" rid="ijms-22-01591-f005">Figure 5</xref>). We evaluated the genes Tyr, Tyrp1, and Dct associated with melanogenesis and the master regulator of cell differentiation Mitf (<xref ref-type="fig" rid="ijms-22-01591-f006">Figure 6</xref>) for pigmentation phenotype. The relative expression (rER) of Ccnd1 decreased for L-Tyr by 0.47 &#x000b1; 0.16 (2.5 X). Exposure to 5-Brd-2&#x02032;-dU induced a decrease of 1.6 X (0.6 &#x000b1; 0.06) (<xref ref-type="fig" rid="ijms-22-01591-f005">Figure 5</xref>a). </p><p>The Cdk4 mRNA showed a decrease concerning the control cells only for L-Tyr with rER of 0.79 &#x000b1; 0.1 (1.25 X) (<xref ref-type="fig" rid="ijms-22-01591-f005">Figure 5</xref>d). As is known, the sustained activation of the binding of the CCDN1 protein to the CDK4 protein kinase allows the early transition from G1 to S in the cell cycle, increasing the phosphorylation of the Rb retinoblastoma protein and releasing the E2F family of transcriptional regulators [<xref rid="B38-ijms-22-01591" ref-type="bibr">38</xref>,<xref rid="B39-ijms-22-01591" ref-type="bibr">39</xref>]. In both cases, the decrease in <italic>Ccnd1</italic> was consistent with the increase in the number of cells arrested in G0/G1 observed in cells exposed to 5-Brd-2&#x02032;-dU (<xref ref-type="fig" rid="ijms-22-01591-f001">Figure 1</xref>e). Although in <italic>Cdk4</italic> it only presented a statistically significant reduction for exposure to L-Tyr, in both cases, the decrease in these mRNAs coincides with the increase in miR-129-5p and 30d-5p (<xref ref-type="fig" rid="ijms-22-01591-f004">Figure 4</xref>d), which as a predictor have <italic>Ccdn1</italic> and <italic>Cdk4</italic> as molecular targets (<xref ref-type="fig" rid="ijms-22-01591-f004">Figure 4</xref>a).</p><p>We observed a reduction in the <italic>Cdk2</italic> in cells exposed to 5-Brd-2&#x02032;-dU (0.36 &#x000b1; 0.09) (2.7 X) and non-significant variation at the mRNA level (1.09 &#x000b1; 0.09) (<xref ref-type="fig" rid="ijms-22-01591-f005">Figure 5</xref>g); however, at the protein level, we found changes for cells exposed to L-Tyr (<xref ref-type="fig" rid="ijms-22-01591-f005">Figure 5</xref>h,i). A set of miRNAs with regulatory potential for each type of treatment from the coincidences reported for <italic>Ccdn1</italic> and <italic>Cdk4</italic>, except for miR-149-5p.</p><p>We founded the decrease in proliferation induced by L-Tyr and 5-Brd-2&#x02032;-dU correlated with an increase in <italic>p21</italic> (rER 2.7 &#x000b1; 0.4) (2.7 X) for cells exposed to L-Tyr and an rER of 0.67 &#x000b1; 0.1 (1.5 X) in cells exposed to 5-Brd-2&#x02032;-dU (<xref ref-type="fig" rid="ijms-22-01591-f005">Figure 5</xref>j). This increase in <italic>p21</italic> would explain, at least in part, the decrease in the S phase for cells exposed to L-Tyr and <italic>CdK2</italic> reduction with the arrest in G2/M (<xref ref-type="fig" rid="ijms-22-01591-f001">Figure 1</xref>e). The p21 expression increased after 7 days, maintaining the exposure (<xref ref-type="fig" rid="ijms-22-01591-f005">Figure 5</xref>m). In this case, the early regulation of the cell cycle by sets of miRNAs presents differential expression. They regulate other targets, such as p27 (increased in western for exposure to 5-Brd-2&#x02032;-dU, data not shown).</p><p>Further, the exposure of B16F1 cells to 5-Brd-2&#x02032;-dU generated a 4 X decrease in the mRNA of all proteins related to melanogenesis, with rER values of 0.24 &#x000b1; 0.069 for <italic>Mitf</italic>, 0.29 &#x000b1; 0.03 for <italic>Tyr</italic>, 0.29 &#x000b1; 0.03 for <italic>Tyrp1</italic>, and in the case of <italic>Dct</italic>, 0.27 &#x000b1; 0.05 (<xref ref-type="fig" rid="ijms-22-01591-f006">Figure 6</xref>a,d,j, respectively); additionally, this reduction related to the protein products obtained in each case (<xref ref-type="fig" rid="ijms-22-01591-f006">Figure 6</xref>b,c,e,f,h&#x02013;k). These results coincide with the drastic reduction in melanin observed in cells exposed to 5-Brd-2&#x02032;-dU (<xref ref-type="fig" rid="ijms-22-01591-f001">Figure 1</xref>f)) [<xref rid="B14-ijms-22-01591" ref-type="bibr">14</xref>,<xref rid="B26-ijms-22-01591" ref-type="bibr">26</xref>,<xref rid="B35-ijms-22-01591" ref-type="bibr">35</xref>]. We did not find significant variations in the expression of Mitf mRNA (1.12 &#x000b1; 0.4) (<xref ref-type="fig" rid="ijms-22-01591-f006">Figure 6</xref>a) and Tyrp1 (0.85 &#x000b1; 0.09) (<xref ref-type="fig" rid="ijms-22-01591-f006">Figure 6</xref>g), but a significant increase for Tyr (1.5 &#x000b1; 0.3) (<xref ref-type="fig" rid="ijms-22-01591-f006">Figure 6</xref>d), and Dct (1.12 &#x000b1; 0.07) (<xref ref-type="fig" rid="ijms-22-01591-f006">Figure 6</xref>g).</p></sec></sec><sec sec-type="discussion" id="sec3-ijms-22-01591"><title>3. Discussion</title><p>The number of reports related to changes in miRNAs&#x02019; expression and their targets in melanoma samples under different tumor progression stages is growing; however, their role in growth suppression models and whether these miRNAs change reciprocally with the phenotype are little known. We present the first report about changes in miRNAs&#x02019; expression profile in mouse B16 melanoma cells under growth suppression and differential pigmentation induced by exposure to the amino acid L-Tyrosine or the thymidine analog 5-Bromo-2&#x02032;-deoxyuridine. We propose some network models of co-expression of microRNAs that present potential common targets associated with cell cycle control, senescence, proliferation, and melanogenesis in the mouse melanoma B16-F1 cells.</p><p>Exposure for 72 h to L-Tyr and 5-Brd-2&#x02032;-dU generates a statistically significant decrease in the number of B16F1 cells (79% and 64%, respectively (<xref ref-type="fig" rid="ijms-22-01591-f001">Figure 1</xref>b and <xref ref-type="app" rid="app1-ijms-22-01591">Figure S1c</xref>)), results that agree with previous reports on B16 cells and other models of melanoma, such as embryonic retinal pigment cells and IIB-MEL-J [<xref rid="B15-ijms-22-01591" ref-type="bibr">15</xref>,<xref rid="B19-ijms-22-01591" ref-type="bibr">19</xref>,<xref rid="B20-ijms-22-01591" ref-type="bibr">20</xref>,<xref rid="B21-ijms-22-01591" ref-type="bibr">21</xref>,<xref rid="B22-ijms-22-01591" ref-type="bibr">22</xref>,<xref rid="B40-ijms-22-01591" ref-type="bibr">40</xref>]. To discriminate the loss of cells by death and cell cycle arrest, we quantified the number of cells in supernatants by I.P. incorporation, and we calculated the population doubling times (<xref ref-type="fig" rid="ijms-22-01591-f001">Figure 1</xref>d; <xref ref-type="app" rid="app1-ijms-22-01591">Figure S1b,c</xref>). The increase from 19.6 &#x000b1; 3.94 h to 48.67 &#x000b1; 6.25 h and 27.03 &#x000b1; 3.0 h induced by 72-h exposure to L-Tyr and 5-Brd-2&#x02032;-dU, respectively, indicates that reduction of the number of cells would be mainly a consequence of variations in the cell cycle control. Cell cycle analysis (<xref ref-type="fig" rid="ijms-22-01591-f001">Figure 1</xref>e), indicating a transition of the G0/G1 phase (from 50 &#x000b1; 3.0% to 66.6 &#x000b1; 2.8%) and G2/M (from 15.7 &#x000b1; 1.6% to 2.4 &#x000b1; 1.2%) for 5-Brd-2&#x02032;-dU and in the S phase for L-Tyr (from 24.4 &#x000b1; 0.7% to 15.8 &#x000b1; 3.6%). The cells exposed to L-Tyr significantly increase the G0/G1 phase (55.5 &#x000b1; 3.8% <italic>n</italic> = 3).</p><p>p16 is mutated in B16 cells [<xref rid="B41-ijms-22-01591" ref-type="bibr">41</xref>] (not shown data); therefore, we decided to evaluate the expression of <italic>p21</italic> to understand the decrease in proliferation induced by L-Tyr and 5-Brd-2&#x02032;-dU. Cells exposed to L-Tyr increase the <italic>p21</italic> expression with an rER 2.7 &#x000b1; 0.4 (2.7 X), and cells exposed to 5-Brd-2&#x02032;-dU decrease <italic>p21</italic> with an rER of 0.67 &#x000b1; 0.1 (1.5 X) (<xref ref-type="fig" rid="ijms-22-01591-f005">Figure 5</xref>j). This increase in <italic>p21</italic> would explain, at least in part, the decrease in the S phase for cells exposed to L-Tyr (<xref ref-type="fig" rid="ijms-22-01591-f001">Figure 1</xref>e), while the reduction of p21 is related to the arrest in G2/M in <italic>CdK2</italic> in 5-Brd-2&#x02032;-dU (<xref ref-type="fig" rid="ijms-22-01591-f001">Figure 1</xref>e) [<xref rid="B42-ijms-22-01591" ref-type="bibr">42</xref>,<xref rid="B43-ijms-22-01591" ref-type="bibr">43</xref>,<xref rid="B44-ijms-22-01591" ref-type="bibr">44</xref>,<xref rid="B45-ijms-22-01591" ref-type="bibr">45</xref>]. CDK2 is a cyclin-dependent kinase that participates in the late transition of G1/S by binding to cyclin E [<xref rid="B46-ijms-22-01591" ref-type="bibr">46</xref>] and in the passage of G2/M by binding to cyclin A [<xref rid="B47-ijms-22-01591" ref-type="bibr">47</xref>]. The late participation of p21 in regulating the cell cycle under exposure to 5-Brd-2&#x02032;-dU [<xref rid="B27-ijms-22-01591" ref-type="bibr">27</xref>] agrees with its high expression after seven days of maintaining the treatment (<xref ref-type="fig" rid="ijms-22-01591-f005">Figure 5</xref>m).</p><p>B16F1 melanoma cells under standardized cell culture conditions [<xref rid="B15-ijms-22-01591" ref-type="bibr">15</xref>,<xref rid="B25-ijms-22-01591" ref-type="bibr">25</xref>] and 5-Brd-2&#x02032;-dU [<xref rid="B14-ijms-22-01591" ref-type="bibr">14</xref>,<xref rid="B21-ijms-22-01591" ref-type="bibr">21</xref>,<xref rid="B26-ijms-22-01591" ref-type="bibr">26</xref>,<xref rid="B35-ijms-22-01591" ref-type="bibr">35</xref>] presented changes in melanin concentrations (<xref ref-type="fig" rid="ijms-22-01591-f001">Figure 1</xref>b) (Pearson&#x02019;s correlation coefficient 0.999). Fluorometry and colorimetry allowed the detection of increase (9 X) and decrease (5 X) in melanin concentration in B16 cells exposed to L-Tyr and 5-Brd-2&#x02032;-dU, respectively (<xref ref-type="fig" rid="ijms-22-01591-f001">Figure 1</xref>f). However, fluorometry was more sensitive (detection limit 0.098 &#x000b5;g.mL<sup>&#x02212;1</sup> and CV of 9.85%); this hyperpigmentation has also been described in primary culture melanocytes exposed to high concentrations of the amino acid L-tyrosine [<xref rid="B48-ijms-22-01591" ref-type="bibr">48</xref>,<xref rid="B49-ijms-22-01591" ref-type="bibr">49</xref>].</p><p>We confirm that exposure to L-Tyr and 5-Brd-2&#x02032;-dU induces an arrest at different points in the cell cycle control for B16F1 cells and differential pigmentation phenotype associated with changes in the expression of genes involved in melanin synthesis [<xref rid="B17-ijms-22-01591" ref-type="bibr">17</xref>,<xref rid="B31-ijms-22-01591" ref-type="bibr">31</xref>,<xref rid="B50-ijms-22-01591" ref-type="bibr">50</xref>]. L-Tyrosine and the thymidine analog, 5-Bromo-2&#x02032;-deoxyuridine induced a decrease in proliferation and pigmentation changes in melanoma B16F1 cells. These phenotypic changes remember terminal differentiation and replicative senescence induced by L-Tyr and 5-Brd-2&#x02032;-dU, respectively.</p><p>5-Brd-2&#x02032;-dU&#x02019;s replicative senescence generates a phenotype associated with induced senescence in different cell models [<xref rid="B27-ijms-22-01591" ref-type="bibr">27</xref>,<xref rid="B28-ijms-22-01591" ref-type="bibr">28</xref>,<xref rid="B29-ijms-22-01591" ref-type="bibr">29</xref>], including B16 cells [<xref rid="B30-ijms-22-01591" ref-type="bibr">30</xref>,<xref rid="B31-ijms-22-01591" ref-type="bibr">31</xref>,<xref rid="B51-ijms-22-01591" ref-type="bibr">51</xref>]. Senescence-associated beta-galactosidase (S.A. &#x003b2;-Gal) assay (<xref ref-type="fig" rid="ijms-22-01591-f002">Figure 2</xref>b) and positivity for the histone H3K9me3 involved in heterochromatin remodeling confirm the senescence phenotype [<xref rid="B52-ijms-22-01591" ref-type="bibr">52</xref>,<xref rid="B53-ijms-22-01591" ref-type="bibr">53</xref>]. Cells exposed to 5-Brd-2&#x02032;-dU show many concentrated foci, which are associated with heterochromatin (SAHF). Some of these SAHF coincide with a greater density obtained by DAPI labeling (<xref ref-type="fig" rid="ijms-22-01591-f002">Figure 2</xref>c) [<xref rid="B32-ijms-22-01591" ref-type="bibr">32</xref>]. Overall, the results of exposure to 5-Brd-2&#x02032;-dU suggest a phenotype associated with senescence and agree with that previously reported in 5-Brd-2&#x02032;-dU-induced senescence models [<xref rid="B33-ijms-22-01591" ref-type="bibr">33</xref>,<xref rid="B34-ijms-22-01591" ref-type="bibr">34</xref>]. Exposure to L-Tyr induces complexity (SSC) and increases cell size (<xref ref-type="fig" rid="ijms-22-01591-f002">Figure 2</xref>d), perhaps due to the increased number of melanosomes required to synthesize and store the melanin produced [<xref rid="B20-ijms-22-01591" ref-type="bibr">20</xref>,<xref rid="B54-ijms-22-01591" ref-type="bibr">54</xref>,<xref rid="B55-ijms-22-01591" ref-type="bibr">55</xref>].</p><p>A global change in miRNA expression profiles by exposure to L-Tyrosine generated 61% of under-expressed miRNAs and 39% over-expressed, compared to 34% and 65% 5-Brd-2&#x02032;-dU. These results suggest that 5-Brd-2&#x02032;-dU&#x02019;s melanoma cells exposed to genotoxic or metabolic stress by L-Tyr generate two expression profiles for the same genetic background, explaining the reduction in growth and changes in the pigmentation described here, depending on the potential regulation on its molecular targets.</p><p>As expected, the results presented here contrast with previous reports of miRNA expression profiles already obtained under discrete stages of melanoma progression. For example, miR-211-5p in this experimental model is over-expressed by the exposure to L-Tyr; in contrast, during tumor progression, miR-211-5p tends to decrease [<xref rid="B56-ijms-22-01591" ref-type="bibr">56</xref>,<xref rid="B57-ijms-22-01591" ref-type="bibr">57</xref>,<xref rid="B58-ijms-22-01591" ref-type="bibr">58</xref>]. For the let-7a family members, under-expressed in both L-Tyr and 5-Brd-2&#x02032;-dU or let-7b overexpressed in 5-Brd-2&#x02032;-dU and reported as a cell cycle regulator in melanoma, possibly through <italic>cyclins D1</italic> and <italic>D3</italic> and <italic>Cdk4</italic> and associated with interference with anchorage-independent growth [<xref rid="B59-ijms-22-01591" ref-type="bibr">59</xref>]. miR-455, high in B16 cells exposed to 5-Brd-2&#x02032;-dU and low in tumor progression [<xref rid="B58-ijms-22-01591" ref-type="bibr">58</xref>,<xref rid="B60-ijms-22-01591" ref-type="bibr">60</xref>]. These findings agree with the notion that some miRNAs are known to participate in tumor progression as a tumor suppressor, oncomiRs, or miRs and may involve a possible reversible tumor reprogramming mechanism through their targets, in processes that include cell proliferation, senescence, and melanogenesis.</p><p>5-Brd-2&#x02032;-dU is a potent tumor cell radiosensitizer [<xref rid="B61-ijms-22-01591" ref-type="bibr">61</xref>]. Its incorporation into DNA generates lesions that include mutations, fragile sites, chromatid-cracking and exchange, micronuclei, and hypermethylation [<xref rid="B27-ijms-22-01591" ref-type="bibr">27</xref>]. DNA damage produces disruptive effects in the patterns of DNA transcription, increase the affinity of nuclear factors, altering the binding of regulatory proteins to the DNA, which may result in changes in cell differentiation, suppressing cell proliferation, and even causing alterations in the plasma membrane cells [<xref rid="B21-ijms-22-01591" ref-type="bibr">21</xref>,<xref rid="B22-ijms-22-01591" ref-type="bibr">22</xref>,<xref rid="B27-ijms-22-01591" ref-type="bibr">27</xref>,<xref rid="B33-ijms-22-01591" ref-type="bibr">33</xref>,<xref rid="B34-ijms-22-01591" ref-type="bibr">34</xref>,<xref rid="B61-ijms-22-01591" ref-type="bibr">61</xref>,<xref rid="B62-ijms-22-01591" ref-type="bibr">62</xref>,<xref rid="B63-ijms-22-01591" ref-type="bibr">63</xref>,<xref rid="B64-ijms-22-01591" ref-type="bibr">64</xref>].</p><p>The results presented herein B16 cells on microRNA expression changes extend our knowledge on other molecular effects generated by 5-Brd-2&#x02032;-dU exposure in terms of a possible regulation of these processes mediated in a post-transcriptional manner. In B16F1 melanoma cells, 5-Brd-2&#x02032;-dU causes an absence of melanosomes, an interruption of the lamellar matrix of the endoplasmic reticulum, and an irregular perinuclear microfilament arrangement [<xref rid="B18-ijms-22-01591" ref-type="bibr">18</xref>].</p><p>We observed changes at the mRNA and protein levels for Tyr and Dct and protein for Tyrp1 without <italic>Mitf</italic> gene expression changes, suggesting that other regulatory mechanisms are related, i.e., regulation mediated by sets of miRNAs. Downregulation of tyrosinase gene expression by 5-Brd-2&#x02032;-dU is not due to incorporating this analog into upstream sequences of the tyrosinase gene. Therefore, the mechanism of pigment inhibition is not elucidated yet [<xref rid="B21-ijms-22-01591" ref-type="bibr">21</xref>,<xref rid="B26-ijms-22-01591" ref-type="bibr">26</xref>,<xref rid="B65-ijms-22-01591" ref-type="bibr">65</xref>]. In contrast, in cells exposed to L-Tyr, the Mitf values did not present statistically significant changes concerning the control cells (<xref ref-type="fig" rid="ijms-22-01591-f006">Figure 6</xref>). As shown here, cells exposed to 5-Brd-2&#x02032;-dU and a decrease in Mitf, the master regulator of melanogenesis, modulate <italic>Tyrosinase</italic>, <italic>Tyrp1</italic>, and <italic>Dct</italic> gene expression [<xref rid="B20-ijms-22-01591" ref-type="bibr">20</xref>,<xref rid="B55-ijms-22-01591" ref-type="bibr">55</xref>,<xref rid="B66-ijms-22-01591" ref-type="bibr">66</xref>,<xref rid="B67-ijms-22-01591" ref-type="bibr">67</xref>,<xref rid="B68-ijms-22-01591" ref-type="bibr">68</xref>,<xref rid="B69-ijms-22-01591" ref-type="bibr">69</xref>] and through the coordinated and simultaneous gene activity interference.</p><p>Pigmentation changes in this model are not mutually exclusive with the suppression of cell growth, which supports the idea of multiple signaling pathways and molecular networks operating differentially to generate a reduction in cell proliferation with differentially hyper or hypopigmentation phenotypes. Perhaps the latter, as a consequence of the phenotype associated with senescence due to 5-Brd-2&#x02032;-dU exposure, evidence widely reported in other models where 5-Brd-2&#x02032;-dU generates hypopigmentation [<xref rid="B21-ijms-22-01591" ref-type="bibr">21</xref>,<xref rid="B26-ijms-22-01591" ref-type="bibr">26</xref>,<xref rid="B70-ijms-22-01591" ref-type="bibr">70</xref>].</p><p>The confirmation of differential expression of some miRNAs by RT-qPCR stem-loop and the prediction of miRNA targets associated with induced phenotypes reveals a different set of miRNAs per challenge 5-Brd-2&#x02032;-dU and Tyr the differential pigmentation phenotype. However, we did not find miRNAs with differential expression by TargetScan that had <italic>Dct</italic> as a target and for miR-27b-3p, which has <italic>Mitf</italic>, <italic>Tyr</italic>, and <italic>Tyrp1</italic> as a common target and miR-148b-3p, reported as a <italic>Mitf</italic> regulator [<xref rid="B71-ijms-22-01591" ref-type="bibr">71</xref>], DESEq2 and RT-qPCR found non-concordant values. In this regard, for exposure to L-Tyr, in PCR, both miRNAs increased their expression concerning the control, a situation also recorded for exposure to 5-Brd-2&#x02032;-dU, a differential expression that was not obtained by sequencing (<xref ref-type="fig" rid="ijms-22-01591-f004">Figure 4</xref>c). This apparent miRNA antagonism is frequent when the differential expression analysis is assessed by different platforms, including microarrays, NGS, and RT-qPCR. It would possibly be associated with the technical effects of each methodology [<xref rid="B72-ijms-22-01591" ref-type="bibr">72</xref>], for what was considered the analysis of expression by PCR as gold standard [<xref rid="B73-ijms-22-01591" ref-type="bibr">73</xref>].</p><p>miR-470-5p targets <italic>Mitf</italic> that regulate Tyr enzyme, which is a target of miR-470-3p; had already been reported before by our laboratory [<xref rid="B18-ijms-22-01591" ref-type="bibr">18</xref>]. Here we confirmed by RT-qPCR (<xref ref-type="fig" rid="ijms-22-01591-f004">Figure 4</xref>c), with an increase due to exposure to 5-Brd-2&#x02032;-dU (22 X for miR-470-5p), but not for L-Tyr. These two miRNAs participate in the differentiation of mouse embryonic cells [<xref rid="B74-ijms-22-01591" ref-type="bibr">74</xref>] and hepatocellular carcinoma [<xref rid="B75-ijms-22-01591" ref-type="bibr">75</xref>]. Our results show that their potential role in the CCDN1/CDK4 complex as an essential oncogenic driver in various cancer types, including melanoma [<xref rid="B76-ijms-22-01591" ref-type="bibr">76</xref>].</p><p>The let-7 family&#x02019;s downward expression agrees with the previous publications [<xref rid="B58-ijms-22-01591" ref-type="bibr">58</xref>,<xref rid="B77-ijms-22-01591" ref-type="bibr">77</xref>,<xref rid="B78-ijms-22-01591" ref-type="bibr">78</xref>] through binding to &#x003b2;3 integrin [<xref rid="B79-ijms-22-01591" ref-type="bibr">79</xref>] and the miR-125a-5p/Lin28B/<italic>let</italic>-7 regulatory circuit [<xref rid="B80-ijms-22-01591" ref-type="bibr">80</xref>], metastasis [<xref rid="B81-ijms-22-01591" ref-type="bibr">81</xref>], metabolism [<xref rid="B82-ijms-22-01591" ref-type="bibr">82</xref>], and the control of the cell cycle by CDK4 and cyclins D1, D3, and A [<xref rid="B59-ijms-22-01591" ref-type="bibr">59</xref>].</p><p>miR-129-5p has been reported in the increase in the size of A375 cells through binding to AEG1 [<xref rid="B83-ijms-22-01591" ref-type="bibr">83</xref>]. In other types of cancer, this miR is related to cell cycle control, proliferation, migration, and invasion [<xref rid="B84-ijms-22-01591" ref-type="bibr">84</xref>] in multiple myeloma, glioma cells [<xref rid="B85-ijms-22-01591" ref-type="bibr">85</xref>,<xref rid="B86-ijms-22-01591" ref-type="bibr">86</xref>], prostate cancer [<xref rid="B87-ijms-22-01591" ref-type="bibr">87</xref>,<xref rid="B88-ijms-22-01591" ref-type="bibr">88</xref>], colorectal cancer [<xref rid="B89-ijms-22-01591" ref-type="bibr">89</xref>], and breast cancer [<xref rid="B90-ijms-22-01591" ref-type="bibr">90</xref>].</p><p>miR-30 family is related to the regulation of proliferation processes via Wnt/&#x003b2;-catenin [<xref rid="B91-ijms-22-01591" ref-type="bibr">91</xref>,<xref rid="B92-ijms-22-01591" ref-type="bibr">92</xref>], cell cycle control [<xref rid="B93-ijms-22-01591" ref-type="bibr">93</xref>], apoptosis [<xref rid="B94-ijms-22-01591" ref-type="bibr">94</xref>,<xref rid="B95-ijms-22-01591" ref-type="bibr">95</xref>] and senescence in various cell models [<xref rid="B96-ijms-22-01591" ref-type="bibr">96</xref>,<xref rid="B97-ijms-22-01591" ref-type="bibr">97</xref>]. In melanoma, it is related to increased cell invasion due to increased aberrant glycosylations associated with its molecular target GALNT7 [<xref rid="B98-ijms-22-01591" ref-type="bibr">98</xref>].</p><p>Pigmented and unpigmented B16 melanoma cells present an expected decrease in cell proliferation. It is possible to suggest that miRNAs share, through their potential targets, a reciprocal and coordinated regulation on the cell cycle&#x02019;s control dependent on the expression level of the specific group of miRNAs, without ignoring the possible differential effect that the regulation of each of them would exert.</p><p>L-Tyr induces melanin production and increases the synthesis of proteins related to melanogenesis as previously reported [<xref rid="B55-ijms-22-01591" ref-type="bibr">55</xref>,<xref rid="B99-ijms-22-01591" ref-type="bibr">99</xref>], trends confirmed in B16F1 cells exposed to L-Tyr (<xref ref-type="fig" rid="ijms-22-01591-f001">Figure 1</xref>f). <italic>Mitf</italic> did not change in cells exposed to L-Tyr; therefore, the differences found at the mRNA and protein levels for TYRP1, as well as the increase in TYR and DCT suggested that, in melanogenesis, other types of post-transcriptional regulation would be involved, such as the differential expression of sets of miRNAs: miR-211-5p and miR-148b-3p, previously reported as regulators of the pigmentation. Different miRNAs regulated <italic>Mitf</italic> and, in turn, is a transcriptional regulator of <italic>p21</italic>, <italic>Cdk2</italic> [<xref rid="B100-ijms-22-01591" ref-type="bibr">100</xref>,<xref rid="B101-ijms-22-01591" ref-type="bibr">101</xref>,<xref rid="B102-ijms-22-01591" ref-type="bibr">102</xref>] and miR-211-5p, the latter, which regulates pigmentation by targeting EDEM1, a TYR inhibitor. miR-211-5p increased to 2.5 X by exposure to L-Tyr and decreased 2 X by 5-Brd-2&#x02032;-dU. We did not find a miR-211-5p direct specific gene target involved in the melanogenesis. However, this was the only miRNA that showed differences between the two phenotypes&#x02014;pigmented and unpigmented melanoma cells. It is exciting that miR-211-5p has been proposed as an indirect regulator of pigmentation through binding to the TGF &#x003b2;-2 receptor, a factor responsible for the transcription of pigmentation-associated genes Dct, TYRP1, TYR, and PMEL17 [<xref rid="B103-ijms-22-01591" ref-type="bibr">103</xref>] and binding to the TYR inhibitor EDEM1 mRNA [<xref rid="B104-ijms-22-01591" ref-type="bibr">104</xref>]; additionally, MITF may regulate the expression of miR-211-5p [<xref rid="B103-ijms-22-01591" ref-type="bibr">103</xref>]. Together, these results suggest a possible pigmentation regulatory circuit in which genes regulated by miR-211 and the MITF factor would be participating, including the coordinated expression of sets of miRNAs.</p><p>The analysis of functional enrichment by KEGG pathways for the differentially expressed miRNAs shows diametrically compromised pathways for each phenotype that reinforce the hypothesis of miRNAs that operate in the regulation of signaling pathways under metabolic stress generated by exposure to L-Tyr (PI3K/Akt, MAPK, mTOR, among others) and miRNAs with potential participation in response pathways to genotoxic stress (p53, FoxO, Jak-STAT and transcriptional alteration in cancer).</p><p>Coordinated and reciprocal miRNA expression changes may explain changes in melanoma phenotypes induced by L-Tyr and 5-Brd-2&#x02032;-dU. miR-211-5p is overexpressed in the hyperpigmented phenotype and downward in the hypopigmented phenotype, without ignoring other miRNAs&#x02019; possible participation such as miR-470-5p miR-148-3p, miR-30d-5p, and miR-27b-3p, which have <italic>Mitf</italic>, <italic>Tyr</italic>, and <italic>Tyrp1</italic> as potential molecular targets. It was striking that exposure to L-Tyr did not affect the expression levels of the gene and protein of MITF, the master regulator of the expression of TYR, TYRP1, and DCT, but for the levels of <italic>Tyr</italic> mRNA, an increase with statistical significance. These results suggest an additional regulation to the transcription factor, possibly involving miR-211-5p, as has already been reported in other models [<xref rid="B104-ijms-22-01591" ref-type="bibr">104</xref>].</p><p>Regarding the control of the cell cycle and senescence in B16F1 melanoma cells, where p16INK4a is truncated [<xref rid="B41-ijms-22-01591" ref-type="bibr">41</xref>], suggests other pathways involved, such as p21, p53 pathway, cyclin D1, Cdk2, Cdk4, Rb, and transcription factors E2F [<xref rid="B105-ijms-22-01591" ref-type="bibr">105</xref>,<xref rid="B106-ijms-22-01591" ref-type="bibr">106</xref>,<xref rid="B107-ijms-22-01591" ref-type="bibr">107</xref>]. </p><p>This bioinformatics approach based on experimental data of differential expression of miRNAs could facilitate the establishment of new hypotheses associated with a differential expression profile, whose expression as a whole could be related to the synchronous regulation of gene expression in particular cellular programs. Recent evidence suggests a possible epigenetic reprogramming by transcriptional modification of miRNA expression profiles [<xref rid="B108-ijms-22-01591" ref-type="bibr">108</xref>]. Based on the results in this experimental model of induced growth suppression and differential pigmentation, cells may reprogram a reversible phenotype through the coordinated and reciprocal regulation of their transcriptome. It is tempting to speculate a possible coordinated response under the stimulus of genotoxic or metabolic stress described above. This response involves the global reprogramming of patterns of miRNA expression and miRNAs relative antagonism.</p><p>A parallel reprogramming in mRNA expression may provide a partial explanation for the changes reported in cell cycle control, senescence, and melanogenesis; new studies are necessary to understand the molecular bases of miRNAs and epigenetic regulation. However, it is necessary to confirm the clusters generated here in the network models and establish the functional network associations between these microRNAs and their mRNAs target in cell cycle control and pigmentation. </p><p>The results apply only to the murine melanoma cell line B16 under specific experimental conditions of this study. They do not allow for any generalization and cannot extrapolate the results found in our work to another melanoma model given the high biological variability. In this regard, we compared the same population of the cell line under two different phenotypes to have the same genetic background to decrease biological variability. While a basis for comparison is still maintained, many differences between cell lines and primary cell cultures and the heterogeneity in melanoma from biopsies or surgical specimens may limit these findings&#x02019; relevance to the miRNA expression. They may be different and questionable for the genetic variations. Therefore, it is necessary to confirm the findings in other melanoma cells, especially in primary human melanoma cultures.</p></sec><sec id="sec4-ijms-22-01591"><title>4. Materials and Methods</title><sec id="sec4dot1-ijms-22-01591"><title>4.1. Cell Line Cultures</title><p>The B16F1 tumor cell line: (ATCC<sup>&#x000ae;</sup> CRL-6322&#x02122;, Manassas, VA, USA), with epithelial morphology and adherent growth, from C57BL/6J mouse skin, was cultivated at 37 &#x000b0;C with 5% CO<sub>2</sub> and 98% humidity (Precision Scientific NAPCO 5410-120 Water Jacketed CO<sub>2</sub> Incubator, Buffalo, NY, USA) in DMEM advance (Dulbecco&#x02019;s modification of Eagles medium) (Gibco, Thermo Fisher Scientific, Waltham, MS, USA) supplemented with 10% (<italic>v</italic>/<italic>v</italic>) fetal bovine serum (SFB) (Gibco), pH 7.2&#x02013;7.4 condition, penicillin (100 U/mL), and streptomycin (100 &#x000b5;g/mL). The cells, at 70% confluence, treated with trypsin-EDTA (Sigma-Aldrich, St. Louis, MO, USA) 0.25% (<italic>m</italic>/<italic>v</italic>), resuspended and counted in automatic Tali&#x02122; Image-based Cytometer (Thermo Fisher Scientific) following the manufacturer&#x02019;s specifications and their viability evaluated in Newbauer&#x02019;s Chamber in dilution 1:1 with Trypan Blue (Sigma-Aldrich).</p></sec><sec id="sec4dot2-ijms-22-01591"><title>4.2. Induction of the Phenotype of Decreased Proliferation and Changes in Pigmentation by Expo-Sure to L-Tyrosine (L-Tyr) or 5-Bromo-2&#x02032;-Deoxyuridine (5-Brd-2&#x02032;-dU)</title><p>We seeded an average of 1.5 &#x000d7; 10<sup>5</sup> B16F1 cells in complete DMEM in a sterile Petri dish (Falcon 3003). Between 10 to 12 h after sowing, we changed by fresh medium supplemented with 5-Brd-2&#x02032;-dU (Sigma-Aldrich) or L-Tyr (Biomedical Inc, Clinton Township, MI, USA) at a final concentration of 2.5 &#x000b5;g/mL and 5 mM, respectively, and incubate for 72 h without medium change. Furthermore, we followed every 48 h for cell monitoring assay until 240 h, where 5.0 &#x000d7; 10<sup>2</sup> cells were seeded to determine population doubling times. The photomicrographs were captured under a 20x inverted light microscope (Nikon Eclipse Ti, Kobe, Japan) using the NIS-Elements-Nikon program. The cells treated with 5-Brd-2&#x02032;-dU, protected from light, were resuspended in complete medium, and the exclusion of Trypan Blue assessed the viability. Additionally, the cells from the culture supernatants recovered by centrifugation, and their viability was determined using propidium iodide (I.P.) incorporation assay in Tali&#x02122; Image-based Cytometer following the manufacturer&#x02019;s specifications.</p></sec><sec id="sec4dot3-ijms-22-01591"><title>4.3. MTT Assay</title><p>B16F1 cells exposed or not to L-Tyr or 5-Brd-2&#x02032;-dU were seeded in a sterile 96-well culture box (Corning, NY, USA); after 10-12 h of incubation, the medium was removed and incubated again for 1h at 37 &#x000b0;C with 0.83 mg.mL<sup>&#x02212;1</sup> of MTT (3 (4.5 dimethylthiazol) 2.5 diphenyl tetrazolium bromide) (Sigma-Aldrich) dissolved in phosphate-buffered saline (PBS). We removed the MTT excess MTT, and dimethyl sulfoxide (DMSO) (Merck, Branchburg, NJ, USA) to help to dissolve the formazan crystals. The wells were read at 560 nm on a GloMax<sup>&#x000ae;</sup>-Multi Detection System (Promega, Madison, WI, USA) following the manufacturer&#x02019;s specifications. To determine the diluted formazan crystals&#x02019; proportionality with the number of viable cells, we constructed a calibration curve using six serials 1:2 dilutions from 8.0 * 10<sup>4</sup> cells. Each well-read read under the same conditions. We assessed population doubling time following the reported protocol [<xref rid="B109-ijms-22-01591" ref-type="bibr">109</xref>].</p></sec><sec id="sec4dot4-ijms-22-01591"><title>4.4. Univariate Analysis of Cell Cycle by Incorporation of Propidium Iodide</title><p>For the cell cycle analysis, we followed the previously reported protocol [<xref rid="B110-ijms-22-01591" ref-type="bibr">110</xref>]. In brief, a total of 1.0 * 10<sup>6</sup> B16F1 cells exposed or not to L-Tyr or 5-Brd-2&#x02032;-dU were fixed in 75% (<italic>v</italic>/<italic>v</italic>) ethanol for 2 h at 4 &#x000b0;C. Excess ethanol was removed and washed with PBS, and the cell pellet was resuspended in propidium iodide (P.I.) staining solution containing: 0.1% (<italic>v</italic>/<italic>v</italic>) Triton X-100 (Sigma-Aldrich); 10 &#x000b5;g.mL<sup>&#x02212;1</sup> of propidium iodide (Sigma-Aldrich) and 100 &#x000b5;g/mL of DNase-free RNase A (Thermo Fisher Scientific) in PBS, protected from light for 30 min at T &#x000b0; room. The cells were analyzed at a flow cytometer (BD FACSAria II &#x02122;, Franklin Lakes, NJ, USA). The fluorescence was measured at 536 nm and 617 nm for excitation and emission, respectively, a total of 1.0 &#x000d7; 10<sup>4</sup> events in three independent replicates. We estimated the relative number of cells using the FlowJo&#x02122; program that assumes Gaussian distributions of the 2N and 4N populations and using a subtractive function to establish the S phase population. Additionally, the cytometer classified the cells according to their size (FSC-A) and its graininess or morphological complexity (SSC-A). Analysis of statistical significance for multiple comparisons without correction, with an alpha = 0.05.</p></sec><sec id="sec4dot5-ijms-22-01591"><title>4.5. Melanin Quantification</title><p>Melanin was quantified by spectrophotometry and fluorometry following previously reported protocols [<xref rid="B23-ijms-22-01591" ref-type="bibr">23</xref>,<xref rid="B24-ijms-22-01591" ref-type="bibr">24</xref>]. In short, we dissolved synthetic melanin (Sigma-Aldrich) 100 &#x000b5;g/mL and melanin from B16F1 cells with 1 M NaOH (Merck) at 80 &#x000b0;C, the collected supernatants after centrifugation (1 min at 12,000&#x000d7; <italic>g</italic> at 4 &#x000b0;C), and we assess the optical density (O.D.) by spectrophotometry at 405 nm. For fluorescence melanin quantification, after incubation with 15% (<italic>m</italic>/<italic>v</italic>) hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) (Sigma-Aldrich), we read the supernatants on the Glomax equipment with a wavelength of 470 nm and 550 nm excitation and emission, respectively. We described the results according to the number of viable cells after determining cell number by MTT reductase assay. Data were expressed as the average of three independent trials &#x000b1; standard deviation and analyzed by unpaired <italic>t</italic>-test with Welch correction and a 95% confidence interval.</p></sec><sec id="sec4dot6-ijms-22-01591"><title>4.6. &#x00392;-Galactosidase Activity Associated with Senescence (S.A. &#x003b2;-Gal)</title><p>To quantify S.A. &#x003b2;-gal activity, we used a previously reported chromogenic assay [<xref rid="B111-ijms-22-01591" ref-type="bibr">111</xref>]. In brief, we fixed B16F1 cells with a 0.2% (<italic>m</italic>/<italic>v</italic>) paraformaldehyde solution (Merck) and 0.2% (<italic>v</italic>/<italic>v</italic>) glutaraldehyde (Sigma-Aldrich) for 10 min at 4 &#x000b0;C. We incubated for 18 h at 37 &#x000b0;C without CO<sub>2</sub> with the substrate and chromogenic solution containing: 1 mg/mL of X-gal reagent (Invitrogen, Carlsbad, CA, USA), 61 mM citric acid/sodium phosphate (pH 4.0, pH 6.0 and pH 7.5; as appropriate), 5 mM K<sub>3</sub>Fe [CN]<sub>6</sub> (Sigma-Aldrich), 5 mM K<sub>4</sub>Fe [CN]<sub>6</sub> (Sigma-Aldrich), 150 mM NaCl (Merck) and 2 mM MgCl<sub>2</sub> (Merck). We documented the changes through a photographic record and spectrophotometric quantification. The staining solution was removed and washed with PBS pH 7.4 at room temperature and protected from light. We dissolved the &#x003b2;-galactosidase product with 200 &#x000b5;L of 99% DMSO by 5 h and then quantified at 600 nm in the Glomax spectrophotometer. Data were expressed as the average of four independent trials &#x000b1; standard deviation and analyzed by unpaired <italic>t</italic>-test with Welch correction and a 95% confidence interval.</p></sec><sec id="sec4dot7-ijms-22-01591"><title>4.7. Protein Detection by Immunofluorescence</title><p>Cells seeded in coverslips in the presence or absence of 5 mM L-Tyr or 2.5 &#x000b5;g/mL 5-Brd-2&#x02032;-dU were fixed with 4% (<italic>m</italic>/<italic>v</italic>) paraformaldehyde in PBS, permeabilized with 0.3% (<italic>v</italic>/<italic>v</italic>) Triton X-100 and incubated with the rabbit polyclonal primary antibody (Santa Cruz Biotechnology Inc, Dallas, TX, USA): anti-Cdk2 (sc-163), anti-Cdk4 (sc-260), anti-cyclin D1 (sc-717), anti-p21 (sc-756), anti-TRP1 (sc-25543), anti-Dct (sc-25544), anti-Tyrosinase-Tyr (sc-15341) or anti-MITF (sc-11002), the latter made in goat. To detect H3K9me3, we used a polyclonal antibody made in rabbits (ab8898) (Abcam, Cambridge, UK), in all cases, final concentration of primary antibody was 0.4 &#x000b5;g/mL. As a secondary antibody, we used a CFL-647-labeled goat anti-rabbit (sc-362292) (Santa Cruz), and for H3K9me3 and MITF, a CFL-488-labeled goat anti-rabbit (sc-362262) and a chicken-marked anti-goat marked with Texas Red (sc-3923), respectively, both from (Santa Cruz) with concentrations and incubation times following manufacturer&#x02019;s recommendations (0.4 &#x000b5;g/mL). After nuclei labeled with DAPI (4&#x02032;,6-diamidino-2-phenylindole) (Sigma-Aldrich) and the coverslips mounted on 25% (<italic>v</italic>/<italic>v</italic>) glycerol (Merck), we acquired the images under an inverted microscope (Eclipse Ti, Kobe, Japan) in a bright field and with the filter corresponding to the used fluorophores. We quantified the mean fluorescence intensities (MFI) and calculated the apparent cell area from the bright-field photographs after defining each cell&#x02019;s perimeter on the NIS-Elements program. </p></sec><sec id="sec4dot8-ijms-22-01591"><title>4.8. Protein Expression by Western Blot</title><p>B16F1 cells were washed with sterile PBS and mechanically lysed in the presence of RIPA buffer (Sigma-Aldrich) containing 1mM phenyl-methyl sulfonyl-fluoride (PMFS) (Sigma-Aldrich) as a protease inhibitor. The samples were centrifuged at 13,000&#x000d7; <italic>g</italic> for 15 min at 4 &#x000b0;C. The supernatant and the protein concentration were quantified using a calibration curve constructed with bovine serum albumin and bicinchoninic acid (Pierce &#x02122; BCA Protein Assay Kitt, Thermo Fisher Scientific) following the manufacturer&#x02019;s recommendations. A total of 30 &#x000b5;g of protein quantified per sample was removed by 10% SDS-PAGE electrophoresis under denaturing conditions. The obtained gels were electro-transferred to a PVDF membrane (Millipore-Merck) using the Novex<sup>&#x000ae;</sup> semi-dry system (Thermo Fisher Scientific) following the manufacturer&#x02019;s recommendations. For immuno-detection, the non-specific sites of the PVDF membrane were blocked with a 1% (<italic>m</italic>/<italic>v</italic>) solution of polyvinylpyrrolidone (PVP-40) (Sigma-Aldrich) in PBS-Tween 20 (Sigma-Aldrich) [<xref rid="B112-ijms-22-01591" ref-type="bibr">112</xref>] and incubated with the primary antibodies used in the immunofluorescence, in addition to p16INK4a/CDKN2A (ab108349) from Abcam and p27 (sc-528) (Santa Cruz). Subsequently, the incubation with the corresponding secondary antibody marked with horseradish peroxidase-HRP (VECTOR, Burlingame, CA, USA): anti-goat made in a horse (PI-9500) and anti-rabbit made in goat (P1-1000). As load control, we used the detection of the nuclear protein Lamina B1 (sc-6216) (Santa Cruz). Finally, the detection was completed by chemiluminescence using ECL-western blotting system (Amersham, Boston, MA, USA) and densitometric analysis in Fiji-ImageJ (<uri xlink:href="https://fiji.sc/">https://fiji.sc/</uri>)</p></sec><sec id="sec4dot9-ijms-22-01591"><title>4.9. Extraction of Total RNA and Enrichment of Small RNAs</title><p>We followed the organic phase RNA extraction as the previously described protocol [<xref rid="B113-ijms-22-01591" ref-type="bibr">113</xref>]. In brief, B16F1 cells were lysed in the presence of TRIzol (Invitrogen) to solubilize the melanin. The lysate was collected in 1.5 mL Eppendorf tubes and heated for 2 min at 65 &#x000b0;C [<xref rid="B114-ijms-22-01591" ref-type="bibr">114</xref>]. By successive centrifugations with chloroform (Sigma-Aldrich), isopropanol (Biomedical Inc.), and 75% ethanol (Merck), the pellet dried at room temperature for 10 min and was resuspended in H2O DEPC (diethyl pirocarbonate, Sigma-Aldrich) for subsequent RT-qPCR assays and quantified by spectrophotometry (Nanodrop 2000, Thermo Fisher Scientific); or resuspended in transport buffer following the manufacturer&#x02019;s recommendations, for subsequent sequencing. To obtain enriched fractions of small RNAs &#x02264; 200 nt, miRVana&#x02122; miRNA Isolation Kit (Ambion, Austin, TX, USA) was used following the manufacturer&#x02019;s recommendations.</p></sec><sec id="sec4dot10-ijms-22-01591"><title>4.10. Small RNAseq</title><p>We used Illumina technology (Illumina, San Diego, California, USA) to sequence small RNAs. Before the library&#x02019;s construction, evaluate the total RNA&#x02019;s quality and integrity on an Agilent RNA ScreenTape System (Illumina) under RNA integrity number (RIN) and TruSeq Small RNA Library Prep Kit (Illumina), following the manufacturer&#x02019;s recommendations. A total RNA fraction coupled to 5&#x02032; and 3&#x02032; adapters to the corresponding RT-PCR for 15 cycles. The amplification products fractionated by 6% polyacrylamide gel electrophoresis, and the amplified library region containing the fraction of miRNAs (140&#x02013;150 nt), was separated, precipitated with ethanol, and quantified on nanodrop. The library was run on a HiSeq 2500 (Illumina) in a fast read-per-cycle 1 &#x000d7; 50 format (single read), averaging 1.0 &#x000d7; 10<sup>7</sup> readings per sample. The quality control and the normalization of the readings obtained using the BaseSpace<sup>&#x000ae;</sup> App, Small RNA v1.0 (Illumina), the sequences converted into FastQ files, and the quality of the readings was analyzed multiQC and confirmed in Galaxy by FastQC (<uri xlink:href="https://usegalaxy.org/">https://usegalaxy.org/</uri>). The alignments for readings obtained between 17 and 35 nt against the reference genome for Mus musculus (mm9) and other databases including miRBase version 21 to identify mature miRNAs (<uri xlink:href="http://www.mirbase.org/">http://www.mirbase.org/</uri>) in whose case was only assigned the name of the miRNAs when we found 100% identity between the reading and the miRBase reference. We registered the data at the Gene Expression Omnibus-GEO-NCBI with the access number GSE147170 (<uri xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE147170">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE147170</uri>).</p></sec><sec id="sec4dot11-ijms-22-01591"><title>4.11. Principal Components Analysis-PCA</title><p>We assessed the PCA in R code under the &#x0201c;plot PCA&#x0201d; function. To summarize the systematic patterns of variation in the readings obtained from the sequencing in principal components, we achieved orthogonal transformation by reducing each sample at one point [<xref rid="B115-ijms-22-01591" ref-type="bibr">115</xref>], provided separate samples by expression variation, and identified possible outliers for each sample. For the construction of the 3D PCA, we used the first three principal components. </p></sec><sec id="sec4dot12-ijms-22-01591"><title>4.12. Differential Expression Analysis of miRNAs from Sequencing Reads</title><p>To determine the differentially expressed miRNAs, we used the DESeq2 (Bioconductor) library in R code; a library specialized in the analysis of count data that provides methods to evaluate the differential expression using the negative binomial distribution and the shrinkage estimator for the distribution of the variance [<xref rid="B116-ijms-22-01591" ref-type="bibr">116</xref>,<xref rid="B117-ijms-22-01591" ref-type="bibr">117</xref>]. We normalized the data by calculating each factor&#x02019;s weight using a function that calculates its weight. With the normalized data, we proceeded to calculate the miRNAs differentially expressed using the &#x0201c;results&#x0201d; function DESeq2 considering differences in expression of those miRNAs with <italic>p</italic>-value adjusted correction multiple, smaller testing 5% [<xref rid="B117-ijms-22-01591" ref-type="bibr">117</xref>]. The miRNAs&#x02019; differential expression values were visualized in heat maps using the &#x0201c;pheatmap&#x0201d; function in R code [<xref rid="B118-ijms-22-01591" ref-type="bibr">118</xref>]; we represented the differential expression data in a grid. Each row represented a miRNA, and each column represented a sample. The squares&#x02019; color and intensity represent changes (not absolute values) of the expression. For illustration purposes, unsupervised clustering using the hierarchical clustering based on the Lance-Williams algorithm was performed using the library pheatmap Raivo Kolde (2019). pheatmap: R package version 1.0.12. <uri xlink:href="https://CRAN.R-project.org/package=pheatmap">https://CRAN.R-project.org/package=pheatmap</uri> and Cluster Analysis Basics and Extensions. R package version 2.1.0. in R [<xref rid="B119-ijms-22-01591" ref-type="bibr">119</xref>,<xref rid="B120-ijms-22-01591" ref-type="bibr">120</xref>].</p></sec><sec id="sec4dot13-ijms-22-01591"><title>4.13. Prediction of Molecular Targets (mRNAs) of microRNAs by TargetScan Mouse</title><p>We selected some molecular targets (mRNAs), which had a previous report of changes in their expression in models of decreased growth and differential pigmentation induced by L-Tyr or 5-Brd-2&#x02032;-dU with B16F1 cells or in other cell models. By using TargetScanMouse 7.1 (<uri xlink:href="http://www.targetscan.org/mmu_71/">http://www.targetscan.org/mmu_71/</uri>), we performed the prediction of all potential miRNAs that could have that gene as a molecular target. The report generated was filtered using the list of miRNAs with differential expression obtained by DESeq2 [<xref rid="B121-ijms-22-01591" ref-type="bibr">121</xref>].</p></sec><sec id="sec4dot14-ijms-22-01591"><title>4.14. RT-qPCR-Stem-Loop for miRNAs and RT-PCR for mRNAs</title><p>We selected seven miRNAs to confirm their expression by RT-qPCR stem-loop. For this, we used a stable loop-type structure (stem-loop) to provide additional length to the target cDNA, optimize its melting temperature (Tm), and improve the assay&#x02019;s specificity (<xref ref-type="app" rid="app1-ijms-22-01591">Table S4</xref>. List of primer sets for genes and miRNAs used in RT-qPCR and RT-qPCR-stem loop). The miRNAs RT and qPCR assays were conducted with the mirVana&#x02122; microRNA Detection Kit (Thermo Fisher Scientific) following the manufacturer&#x02019;s recommendations. We started with 65 ng of RNA for RT, and cDNA synthesis run in a thermocycler (BIO-RAD, Hercules, California, USA): 30 min at 16 &#x000b0;C, 30 min at 42 &#x000b0;C, and 5 min at 85 &#x000b0;C. For qPCR, we used 2.5 &#x000b5;g of cDNA in the Chromo4&#x02122; thermal cycler (BIO-RAD) under the program: 3 min at 95 &#x000b0;C and 40 cycles: 15 s at 95 &#x000b0;C for denaturation, followed by 1 min at 60 &#x000b0;C for ringing and 1 min at 72 &#x000b0;C extensions, after 40 cycles a final extension left at 72 &#x000b0;C for 10 min.</p><p>For the RT-qPCR of the mRNAs, we synthesized cDNA from 2 ng of total RNA and 500 &#x000b5;g/mL of OligodT (Invitrogen) and Superscript II reverse transcriptase (Invitrogen); the samples were run in a thermal cycler (BIO-RAD) for 50 min at 42 &#x000b0;C and 15 min at 70 &#x000b0;C. For real-time PCR (qPCR), 600 ng of cDNA, the sense and antisense primers corresponding to each evaluated mRNA (<xref ref-type="app" rid="app1-ijms-22-01591">Table S4</xref>. Primers list), and DyNAmo HS SYBR Green Kit (Thermo Fisher Scientific) were used, following the manufacturer&#x02019;s recommendations. The amplification in a BIO-RAD Chromo4&#x02122; under the following conditions: 95 &#x000b0;C 15 min to activate the polymerase and 36 cycles that included 10 s at 96 &#x000b0;C to denature, 30 s annealing temperature according to each set of primers, and 30 s at 72 &#x000b0;C extension. We identified the respective melting curve of 55&#x02013;95 &#x000b0;C with data obtained from the Opticon Monitor 3 (BIO-RAD) program for both qPCRs of miRNAs and mRNAs. To quantify mRNA and miRNA Differential expression analysis with qPCR, we use the relative expression ratio (rER) model to establish the mRNAs&#x02019; miRNAs&#x02019; differential expression [<xref rid="B122-ijms-22-01591" ref-type="bibr">122</xref>]. This method adjusts the expression level according to the efficiency of each PCR run. As references, we used GAPDH for mRNAs or U6 snRNA for miRNAs.</p></sec><sec id="sec4dot15-ijms-22-01591"><title>4.15. Construction of Co-Expression Networks for miRNAs (RC-miR)</title><p>For the RC-miR construction, we used the previously proposed [<xref rid="B123-ijms-22-01591" ref-type="bibr">123</xref>], all in R code. The structure of these networks began with creating a similarity matrix, followed by selecting the similarity threshold, constructing an adjacency matrix, and plotting the generated groupings. It found that the relationship between miRNAs was not linear, so the calculation of the similarity matrix of each of the expression matrices was made with the criterion of mutual information (M.I.) because M.I. is capable of detecting nonlinear correlations that are undetectable for other metrics such as the Pearson coefficient [<xref rid="B124-ijms-22-01591" ref-type="bibr">124</xref>]. It was necessary to perform a discretization of the normalized expression data, and we used the &#x0201c;Equal Frequency&#x0201d; method. Finally, the values were adjusted to a correlation coefficient between [0, 1] [<xref rid="B125-ijms-22-01591" ref-type="bibr">125</xref>]. We constructed six matrices of similarity by using the M.I. coefficient as a similarity metric and the expression matrix that included the normalized counts of the Small RNA-seq for the miRNAs with differential expression found in the B16F1 cells exposed or not to L-Tyr or 5-Brd-2&#x02032;-dU, expressed in blocks or by groups: over or under-expressed. We established a similarity threshold to build the adjacency matrix from which the correlation (similarity) between two miRNAs was considered significant. We selected this threshold by comparing the grouping coefficient of the obtained network (<italic>C</italic>(<italic>&#x003c4;</italic>)) and the expected grouping coefficient for a random network (<italic>Co</italic>(<italic>&#x003c4;v</italic>)), with different values of (tao) <italic>&#x003c4;</italic> between 0.01 and 0.99 (Equation (1)) [<xref rid="B123-ijms-22-01591" ref-type="bibr">123</xref>,<xref rid="B126-ijms-22-01591" ref-type="bibr">126</xref>].
<disp-formula id="FD1-ijms-22-01591"><label>(1)</label><mml:math id="mm1"><mml:mrow><mml:mrow><mml:msup><mml:mtext>&#x000a0;</mml:mtext><mml:mo>&#x02217;</mml:mo></mml:msup><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:msub><mml:mi>&#x003c4;</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo>:</mml:mo><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>C</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003c4;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mi>C</mml:mi><mml:mi>r</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003c4;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mo>|</mml:mo><mml:mtext>&#x000a0;</mml:mtext><mml:mo>&#x0003e;</mml:mo><mml:mtext>&#x000a0;</mml:mtext></mml:mrow></mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:mi>C</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003c4;</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mi>C</mml:mi><mml:mi>r</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003c4;</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>|</mml:mo><mml:mo>}</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>As the RC-miRs are non-directed networks, we generated an adjacency matrix (A), indicating which nodes were connected and composed only of ones and zeros generated following Equation (2).
<disp-formula id="FD2-ijms-22-01591"><label>(2)</label><mml:math id="mm2"><mml:mrow><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mtext>&#x000a0;</mml:mtext><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:mi>i</mml:mi><mml:mi>i</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mtext>&#x000a0;</mml:mtext><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:msub><mml:mo>|</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>|</mml:mo><mml:mtext>&#x000a0;</mml:mtext><mml:mo>&#x0003e;</mml:mo><mml:mtext>&#x000a0;</mml:mtext><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mtext>&#x000a0;</mml:mtext><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>We visualized the network using the <italic>igraph</italic> library in R, and we achieved the graphs obtained representing the co-expression networks of miRNAs from multiple experiments.</p></sec><sec id="sec4dot16-ijms-22-01591"><title>4.16. Regulation Networks and Functional Enrichment</title><p>We used miRNet to construct regulatory network models (<uri xlink:href="https://www.mirnet.ca/">https://www.mirnet.ca/</uri>), an open-access web-based tool that integrates multiple statistical tools, data mining, and visualization systems miRNA-target interaction studies [<xref rid="B127-ijms-22-01591" ref-type="bibr">127</xref>,<xref rid="B128-ijms-22-01591" ref-type="bibr">128</xref>]. In addition to implementing a flexible interface to filter, refine, and personalize data during network creation, miRNet contains a network visualization system with the possibility of functional enrichment analysis via KEGG, G.O., and Reactome signaling pathways. Tool fed with miRNAs I.D.s over or under-expressed by exposure to L-Tyr or 5-Brd-2&#x02032;-dU, and for functional enrichment, we used the KEGG signaling pathways and statistical analysis hypergeometric test.</p></sec><sec id="sec4dot17-ijms-22-01591"><title>4.17. Statistic Analysis</title><p>We used an unpaired Student&#x02019;s <italic>t</italic>-test to test for significant differences between each exposure and control. Except where otherwise noted, the number of independent replicates used in the statistical analyses was three; values reported as mean &#x000b1; S.D. and results were considered not significant (ns) with <italic>p</italic> &#x0003e; 0.05, significant (*) with <italic>p</italic> &#x0003c; 0.05, very significant (**) with <italic>p</italic> &#x0003c; 0.01, highly significant (***) with <italic>p</italic> &#x0003c; 0.001 and very highly significant (****) with <italic>p</italic> &#x0003c; 0.0001. For multiple tests, the significance level (a two-tailed <italic>t</italic>-multiple test was performed *), and the differences were considered statistically significant for a <italic>p</italic>-value &#x0003c; 0.05 using the Holm&#x02013;Sidak method with GraphPad Prism<sup>&#x000ae;</sup> (Graphpad Software Inc., La Jolla, CA, USA). The functional enrichment by KEGG signaling pathways in the miRNet web tool included hypergeometric tests and was considered statistically significant for <italic>p</italic> &#x0003c; 0.05 values. Finally, the significance statistic of differentially expressed microRNAs from small RNAseq counts was carried out with DESeq2 algorithm in R code and included the correction of multiple tests.</p></sec></sec><sec sec-type="conclusions" id="sec5-ijms-22-01591"><title>5. Conclusions</title><p>L-Tyr and 5-Brd-2&#x02032;-dU induces a profile of microRNAs in the melanoma cell line B16F1. We identified potential miRNA antagonism and coordination networks on genes involved in pigmentation, cell cycle control, and senescence.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors thanks the National Institute of Health Colombia (INS) and the National University of Colombia (UNAL).</p></ack><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><app-group><app id="app1-ijms-22-01591"><title>Supplementary Materials</title><p>Supplementary materials can be found at <uri xlink:href="https://www.mdpi.com/1422-0067/22/4/1591/s1">https://www.mdpi.com/1422-0067/22/4/1591/s1</uri>.</p><supplementary-material content-type="local-data" id="ijms-22-01591-s001"><media xlink:href="ijms-22-01591-s001.zip"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, H.M.R. and L.A.G.; methodology, H.M.R. and L.A.G.; software, D.O., M.F. and M.C.; validation, H.M.R. and E.N.M.; formal analysis, H.M.R., E.N.M., D.O., M.F. and M.C.; investigation, H.M.R., E.N.M. and L.A.G.; data curation, H.M.R., D.O., M.F. and M.C.; writing&#x02014;original draft preparation, H.M.R. and E.N.M.; writing&#x02014;review and editing, H.M.R. and L.A.G.; visualization, H.M.R. and L.A.G.; supervision, L.A.G.; project direction, L.A.G. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research was funded by resources from the National Institute of Health Colombia. Project-grant No. CETIN-01-2016 (to LAG). HMR is a recipient of a Doctoral Program Fellowship. The support that HMR received from COLCIENCIAS, MinCiencias and INS is acknowledged.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable for studies not involving humans or animals.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable for studies not involving humans.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Publicly available datasets were analyzed in this study. This data can be found here [<uri xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE147170">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE147170</uri>].</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-ijms-22-01591"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aftab</surname><given-names>M.N.</given-names></name><name><surname>Dinger</surname><given-names>M.E.</given-names></name><name><surname>Perera</surname><given-names>R.J.</given-names></name></person-group><article-title>The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma</article-title><source>Arch. Biochem. Biophys.</source><year>2014</year><volume>563</volume><fpage>60</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2014.07.022</pub-id><?supplied-pmid 25065585?><pub-id pub-id-type="pmid">25065585</pub-id></element-citation></ref><ref id="B2-ijms-22-01591"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damsky</surname><given-names>W.E.</given-names></name><name><surname>Theodosakis</surname><given-names>N.</given-names></name><name><surname>Bosenberg</surname><given-names>M.</given-names></name></person-group><article-title>Melanoma metastasis: New concepts and evolving paradigms</article-title><source>Oncogene</source><year>2014</year><volume>33</volume><fpage>2413</fpage><lpage>2422</lpage><pub-id pub-id-type="doi">10.1038/onc.2013.194</pub-id><?supplied-pmid 23728340?><pub-id pub-id-type="pmid">23728340</pub-id></element-citation></ref><ref id="B3-ijms-22-01591"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haass</surname><given-names>N.K.</given-names></name><name><surname>Smalley</surname><given-names>K.S.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Herlyn</surname><given-names>M.</given-names></name></person-group><article-title>Adhesion, migration and communication in melanocytes and melanoma</article-title><source>Pigment Cell Res.</source><year>2005</year><volume>18</volume><fpage>150</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0749.2005.00235.x</pub-id><?supplied-pmid 15892711?><pub-id pub-id-type="pmid">15892711</pub-id></element-citation></ref><ref id="B4-ijms-22-01591"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarkar</surname><given-names>D.</given-names></name><name><surname>Leung</surname><given-names>E.Y.</given-names></name><name><surname>Baguley</surname><given-names>B.C.</given-names></name><name><surname>Finlay</surname><given-names>G.J.</given-names></name><name><surname>Askarian-Amiri</surname><given-names>M.E.</given-names></name></person-group><article-title>Epigenetic regulation in human melanoma: Past and future</article-title><source>Epigenetics</source><year>2015</year><volume>10</volume><fpage>103</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1080/15592294.2014.1003746</pub-id><?supplied-pmid 25587943?><pub-id pub-id-type="pmid">25587943</pub-id></element-citation></ref><ref id="B5-ijms-22-01591"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.T.</given-names></name></person-group><article-title>Epigenetic regulation by long noncoding RNAs</article-title><source>Science</source><year>2012</year><volume>338</volume><fpage>1435</fpage><lpage>1439</lpage><pub-id pub-id-type="doi">10.1126/science.1231776</pub-id><?supplied-pmid 23239728?><pub-id pub-id-type="pmid">23239728</pub-id></element-citation></ref><ref id="B6-ijms-22-01591"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glud</surname><given-names>M.</given-names></name><name><surname>Gniadecki</surname><given-names>R.</given-names></name></person-group><article-title>MicroRNAs in the pathogenesis of malignant melanoma</article-title><source>J. Eur. Acad. Dermatol. Venereol.</source><year>2013</year><volume>27</volume><fpage>142</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1111/j.1468-3083.2012.04579.x</pub-id><?supplied-pmid 22621697?><pub-id pub-id-type="pmid">22621697</pub-id></element-citation></ref><ref id="B7-ijms-22-01591"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunz</surname><given-names>M.</given-names></name></person-group><article-title>MicroRNAs in melanoma biology</article-title><source>Adv. Exp. Med. Biol.</source><year>2013</year><volume>774</volume><fpage>103</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1007/978-94-007-5590-1_6</pub-id><?supplied-pmid 23377970?><pub-id pub-id-type="pmid">23377970</pub-id></element-citation></ref><ref id="B8-ijms-22-01591"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mione</surname><given-names>M.</given-names></name><name><surname>Bosserhoff</surname><given-names>A.</given-names></name></person-group><article-title>MicroRNAs in melanocyte and melanoma biology</article-title><source>Pigment Cell Melanoma Res.</source><year>2015</year><volume>28</volume><fpage>340</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1111/pcmr.12346</pub-id><?supplied-pmid 25515738?><pub-id pub-id-type="pmid">25515738</pub-id></element-citation></ref><ref id="B9-ijms-22-01591"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ameres</surname><given-names>S.L.</given-names></name><name><surname>Zamore</surname><given-names>P.D.</given-names></name></person-group><article-title>Diversifying microRNA sequence and function</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2013</year><volume>14</volume><fpage>475</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1038/nrm3611</pub-id><?supplied-pmid 23800994?><pub-id pub-id-type="pmid">23800994</pub-id></element-citation></ref><ref id="B10-ijms-22-01591"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>D.C.</given-names></name></person-group><article-title>Genetics of melanoma progression: The rise and fall of cell senescence</article-title><source>Pigment Cell Melanoma Res.</source><year>2015</year><pub-id pub-id-type="doi">10.1111/pcmr.12422</pub-id><?supplied-pmid 26386262?><pub-id pub-id-type="pmid">26386262</pub-id></element-citation></ref><ref id="B11-ijms-22-01591"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>P.E.</given-names></name><name><surname>Bemis</surname><given-names>L.</given-names></name><name><surname>Norris</surname><given-names>D.A.</given-names></name><name><surname>Shellman</surname><given-names>Y.G.</given-names></name></person-group><article-title>miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma</article-title><source>Physiol. Genom.</source><year>2013</year><volume>45</volume><fpage>1049</fpage><lpage>1059</lpage><pub-id pub-id-type="doi">10.1152/physiolgenomics.00116.2013</pub-id><?supplied-pmid 24046283?><pub-id pub-id-type="pmid">24046283</pub-id></element-citation></ref><ref id="B12-ijms-22-01591"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pritchard</surname><given-names>C.C.</given-names></name><name><surname>Cheng</surname><given-names>H.H.</given-names></name><name><surname>Tewari</surname><given-names>M.</given-names></name></person-group><article-title>MicroRNA profiling: Approaches and considerations</article-title><source>Nat. Rev. Genet.</source><year>2012</year><volume>13</volume><fpage>358</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1038/nrg3198</pub-id><?supplied-pmid 22510765?><pub-id pub-id-type="pmid">22510765</pub-id></element-citation></ref><ref id="B13-ijms-22-01591"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shain</surname><given-names>A.H.</given-names></name><name><surname>Yeh</surname><given-names>I.</given-names></name><name><surname>Kovalyshyn</surname><given-names>I.</given-names></name><name><surname>Sriharan</surname><given-names>A.</given-names></name><name><surname>Talevich</surname><given-names>E.</given-names></name><name><surname>Gagnon</surname><given-names>A.</given-names></name><name><surname>Dummer</surname><given-names>R.</given-names></name><name><surname>North</surname><given-names>J.</given-names></name><name><surname>Pincus</surname><given-names>L.</given-names></name><name><surname>Ruben</surname><given-names>B.</given-names></name><etal/></person-group><article-title>The Genetic Evolution of Melanoma from Precursor Lesions</article-title><source>N. Engl. J. Med.</source><year>2015</year><volume>373</volume><fpage>1926</fpage><lpage>1936</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1502583</pub-id><?supplied-pmid 26559571?><pub-id pub-id-type="pmid">26559571</pub-id></element-citation></ref><ref id="B14-ijms-22-01591"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez</surname><given-names>L.A.</given-names></name><name><surname>Strasberg Rieber</surname><given-names>M.</given-names></name><name><surname>Rieber</surname><given-names>M.</given-names></name></person-group><article-title>Decrease in actin gene expression in melanoma cells compared to melanocytes is partly counteracted by BrdU-induced cell adhesion and antagonized by L-tyrosine induction of terminal differentiation</article-title><source>Biochem. Biophys. Res. Commun.</source><year>1995</year><volume>216</volume><fpage>84</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1995.2595</pub-id><pub-id pub-id-type="pmid">7488128</pub-id></element-citation></ref><ref id="B15-ijms-22-01591"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rieber</surname><given-names>M.</given-names></name><name><surname>Rieber</surname><given-names>M.S.</given-names></name></person-group><article-title>Cyclin-dependent kinase 2 and cyclin A interaction with E2F are targets for tyrosine induction of B16 melanoma terminal differentiation</article-title><source>Cell Growth Differ.</source><year>1994</year><volume>5</volume><fpage>1339</fpage><lpage>1346</lpage><pub-id pub-id-type="pmid">7696182</pub-id></element-citation></ref><ref id="B16-ijms-22-01591"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strasberg Rieber</surname><given-names>M.</given-names></name><name><surname>Rieber</surname><given-names>M.</given-names></name></person-group><article-title>Suppression of cyclin D1 but not cdk4 or cyclin A with induction of melanoma terminal differentiation</article-title><source>Biochem. Biophys. Res. Commun.</source><year>1995</year><volume>216</volume><fpage>422</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1995.2640</pub-id><pub-id pub-id-type="pmid">7488122</pub-id></element-citation></ref><ref id="B17-ijms-22-01591"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rieber</surname><given-names>M.</given-names></name><name><surname>Strasberg-Rieber</surname><given-names>M.</given-names></name></person-group><article-title>Induction of p53 and melanoma cell death is reciprocal with down-regulation of E2F, cyclin D1 and pRB</article-title><source>Int. J. Cancer</source><year>1998</year><volume>76</volume><fpage>757</fpage><lpage>760</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-0215(19980529)76:5&#x0003c;757::AID-IJC22&#x0003e;3.0.CO;2-#</pub-id><pub-id pub-id-type="pmid">9610736</pub-id></element-citation></ref><ref id="B18-ijms-22-01591"><label>18.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fl&#x000f3;rez Vargas</surname><given-names>&#x000d3;.R.</given-names></name><name><surname>Gomez</surname><given-names>L.A.</given-names></name></person-group><source>Expresi&#x000f3;n Diferencial de dos microRNAs Asociados con el Silenciamiento de la Ciclina D1 en C&#x000e9;lulas de Melanoma B16 en Senescencia Inducida por la 5-Bromo-2-desoxiuridina.Tesis de Maestr&#x000ed;a</source><publisher-name>Universidad Nacional de Colombia</publisher-name><publisher-loc>Bogot&#x000e1;, Colombia</publisher-loc><year>2008</year></element-citation></ref><ref id="B19-ijms-22-01591"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silagi</surname><given-names>S.</given-names></name><name><surname>Bruce</surname><given-names>S.A.</given-names></name></person-group><article-title>Suppression of malignancy and differentiation in melanotic melanoma cells</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1970</year><volume>66</volume><fpage>72</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1073/pnas.66.1.72</pub-id><pub-id pub-id-type="pmid">4921328</pub-id></element-citation></ref><ref id="B20-ijms-22-01591"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerra</surname><given-names>L.</given-names></name><name><surname>Bover</surname><given-names>L.</given-names></name><name><surname>Mordoh</surname><given-names>J.</given-names></name></person-group><article-title>Differentiating effect of L-tyrosine on the human melanoma cell line IIB-MEL-J</article-title><source>Exp. Cell Res.</source><year>1990</year><volume>188</volume><fpage>61</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/0014-4827(90)90278-I</pub-id><pub-id pub-id-type="pmid">2328778</pub-id></element-citation></ref><ref id="B21-ijms-22-01591"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>R.I.</given-names></name><name><surname>Werner</surname><given-names>I.</given-names></name><name><surname>Szabo</surname><given-names>G.</given-names></name></person-group><article-title>Effect of 5-bromo-2&#x02032;-deoxyuridine on growth and differentiation of cultured embryonic retinal pigment cells</article-title><source>In Vitro</source><year>1979</year><volume>15</volume><fpage>779</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1007/BF02618304</pub-id><pub-id pub-id-type="pmid">118105</pub-id></element-citation></ref><ref id="B22-ijms-22-01591"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levkoff</surname><given-names>L.H.</given-names></name><name><surname>Marshall</surname><given-names>G.P.</given-names><suffix>II</suffix></name><name><surname>Ross</surname><given-names>H.H.</given-names></name><name><surname>Caldeira</surname><given-names>M.</given-names></name><name><surname>Reynolds</surname><given-names>B.A.</given-names></name><name><surname>Cakiroglu</surname><given-names>M.</given-names></name><name><surname>Mariani</surname><given-names>C.L.</given-names></name><name><surname>Streit</surname><given-names>W.J.</given-names></name><name><surname>Laywell</surname><given-names>E.D.</given-names></name></person-group><article-title>Bromodeoxyuridine inhibits cancer cell proliferation in vitro and in vivo</article-title><source>Neoplasia</source><year>2008</year><volume>10</volume><fpage>804</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.1593/neo.08382</pub-id><?supplied-pmid 18680882?><pub-id pub-id-type="pmid">18680882</pub-id></element-citation></ref><ref id="B23-ijms-22-01591"><label>23.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ramirez</surname><given-names>C.A.</given-names></name><name><surname>Gomez</surname><given-names>L.A.</given-names></name></person-group><source>Extracci&#x000f3;n y Solubilidad de la Melanina Total Producida por C&#x000e9;lulas de Melanoma Murino B16 Expuestas al Amino&#x000e1;cido L-Tirosina</source><publisher-name>Instituto Nacional de Salud</publisher-name><publisher-loc>Bogot&#x000e1;, Colombia</publisher-loc><year>2005</year></element-citation></ref><ref id="B24-ijms-22-01591"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>B.</given-names></name><name><surname>Matama</surname><given-names>T.</given-names></name><name><surname>Guimaraes</surname><given-names>D.</given-names></name><name><surname>Gomes</surname><given-names>A.</given-names></name><name><surname>Cavaco-Paulo</surname><given-names>A.</given-names></name></person-group><article-title>Fluorescent quantification of melanin</article-title><source>Pigment Cell Melanoma Res.</source><year>2016</year><volume>29</volume><fpage>707</fpage><lpage>712</lpage><pub-id pub-id-type="doi">10.1111/pcmr.12535</pub-id><?supplied-pmid 27770559?><pub-id pub-id-type="pmid">27770559</pub-id></element-citation></ref><ref id="B25-ijms-22-01591"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulrich</surname><given-names>K.</given-names></name><name><surname>Tritsch</surname><given-names>G.L.</given-names></name><name><surname>Moore</surname><given-names>G.E.</given-names></name></person-group><article-title>Tyrosine utilization by pigmented hamster melanoma cells cultured in vitro</article-title><source>Int. J. Cancer</source><year>1968</year><volume>3</volume><fpage>446</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1002/ijc.2910030405</pub-id><pub-id pub-id-type="pmid">5682441</pub-id></element-citation></ref><ref id="B26-ijms-22-01591"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wrathall</surname><given-names>J.R.</given-names></name><name><surname>Oliver</surname><given-names>C.</given-names></name><name><surname>Silagi</surname><given-names>S.</given-names></name><name><surname>Essner</surname><given-names>E.</given-names></name></person-group><article-title>Suppression of pigmentation in mouse melanoma cells by 5-bromodeoxyuridine: Effects on tyrosinase activity and melanosome formation</article-title><source>J. Cell Biol.</source><year>1973</year><volume>57</volume><fpage>406</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1083/jcb.57.2.406</pub-id><pub-id pub-id-type="pmid">4633171</pub-id></element-citation></ref><ref id="B27-ijms-22-01591"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masterson</surname><given-names>J.C.</given-names></name><name><surname>O&#x02019;Dea</surname><given-names>S.</given-names></name></person-group><article-title>5-Bromo-2-deoxyuridine activates DNA damage signalling responses and induces a senescence-like phenotype in p16-null lung cancer cells</article-title><source>Anticancer Drugs</source><year>2007</year><volume>18</volume><fpage>1053</fpage><lpage>1068</lpage><pub-id pub-id-type="doi">10.1097/CAD.0b013e32825209f6</pub-id><pub-id pub-id-type="pmid">17704656</pub-id></element-citation></ref><ref id="B28-ijms-22-01591"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Michishita</surname><given-names>E.</given-names></name><name><surname>Ogino</surname><given-names>H.</given-names></name><name><surname>Fujii</surname><given-names>M.</given-names></name><name><surname>Ayusawa</surname><given-names>D.</given-names></name></person-group><article-title>Synergistic induction of the senescence-associated genes by 5-bromodeoxyuridine and AT-binding ligands in HeLa cells</article-title><source>Exp. Cell Res.</source><year>2002</year><volume>276</volume><fpage>174</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1006/excr.2002.5524</pub-id><pub-id pub-id-type="pmid">12027447</pub-id></element-citation></ref><ref id="B29-ijms-22-01591"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Minagawa</surname><given-names>S.</given-names></name><name><surname>Michishita</surname><given-names>E.</given-names></name><name><surname>Ogino</surname><given-names>H.</given-names></name><name><surname>Fujii</surname><given-names>M.</given-names></name><name><surname>Mitsui</surname><given-names>Y.</given-names></name><name><surname>Ayusawa</surname><given-names>D.</given-names></name></person-group><article-title>Induction of senescence-associated genes by 5-bromodeoxyuridine in HeLa cells</article-title><source>Exp. Gerontol.</source><year>2001</year><volume>36</volume><fpage>465</fpage><lpage>474</lpage><pub-id pub-id-type="doi">10.1016/S0531-5565(00)00223-0</pub-id><pub-id pub-id-type="pmid">11250118</pub-id></element-citation></ref><ref id="B30-ijms-22-01591"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasztor</surname><given-names>L.M.</given-names></name><name><surname>Hu</surname><given-names>F.</given-names></name></person-group><article-title>An amelanotic variant of B16 malignant melanoma</article-title><source>Cancer Res.</source><year>1972</year><volume>32</volume><fpage>1769</fpage><lpage>1774</lpage><pub-id pub-id-type="pmid">5044135</pub-id></element-citation></ref><ref id="B31-ijms-22-01591"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez</surname><given-names>L.A.</given-names></name><name><surname>Strasberg Rieber</surname><given-names>M.</given-names></name><name><surname>Rieber</surname><given-names>M.</given-names></name></person-group><article-title>PCR-mediated differential display and cloning of a melanocyte gene decreased in malignant melanoma and up-regulated with sensitization to DNA damage</article-title><source>DNA Cell Biol.</source><year>1996</year><volume>15</volume><fpage>423</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1089/dna.1996.15.423</pub-id><?supplied-pmid 8924217?><pub-id pub-id-type="pmid">8924217</pub-id></element-citation></ref><ref id="B32-ijms-22-01591"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narita</surname><given-names>M.</given-names></name><name><surname>Nunez</surname><given-names>S.</given-names></name><name><surname>Heard</surname><given-names>E.</given-names></name><name><surname>Narita</surname><given-names>M.</given-names></name><name><surname>Lin</surname><given-names>A.W.</given-names></name><name><surname>Hearn</surname><given-names>S.A.</given-names></name><name><surname>Spector</surname><given-names>D.L.</given-names></name><name><surname>Hannon</surname><given-names>G.J.</given-names></name><name><surname>Lowe</surname><given-names>S.W.</given-names></name></person-group><article-title>Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence</article-title><source>Cell</source><year>2003</year><volume>113</volume><fpage>703</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(03)00401-X</pub-id><pub-id pub-id-type="pmid">12809602</pub-id></element-citation></ref><ref id="B33-ijms-22-01591"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epstein</surname><given-names>W.L.</given-names></name><name><surname>Fukuyama</surname><given-names>K.</given-names></name><name><surname>Drake</surname><given-names>T.E.</given-names></name></person-group><article-title>Ultrastructural effects of thymidine analogs in melanosomes and virus activation in cloned hamster melanoma cells in culture</article-title><source>Yale J. Biol. Med.</source><year>1973</year><volume>46</volume><fpage>471</fpage><lpage>481</lpage><pub-id pub-id-type="pmid">4798393</pub-id></element-citation></ref><ref id="B34-ijms-22-01591"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>P.M.</given-names></name></person-group><article-title>The effect of 5-bromodeoxyuridine on messenger RNA production in cultured cells</article-title><source>Biochim. Biophys. Acta</source><year>1976</year><volume>447</volume><fpage>304</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1016/0005-2787(76)90053-8</pub-id><pub-id pub-id-type="pmid">987803</pub-id></element-citation></ref><ref id="B35-ijms-22-01591"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rieber</surname><given-names>M.</given-names></name><name><surname>Rieber</surname><given-names>M.S.</given-names></name><name><surname>Urbina</surname><given-names>C.</given-names></name><name><surname>Lira</surname><given-names>R.</given-names></name></person-group><article-title>Differential response of adherent and unanchored melanoma cells to bromodeoxyuridine evidenced by specific lectin-binding protein changes</article-title><source>Int. J. Cancer</source><year>1989</year><volume>43</volume><fpage>841</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1002/ijc.2910430517</pub-id><?supplied-pmid 2714888?><pub-id pub-id-type="pmid">2714888</pub-id></element-citation></ref><ref id="B36-ijms-22-01591"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>D.W.</given-names></name><name><surname>Rehli</surname><given-names>M.</given-names></name><name><surname>Bosserhoff</surname><given-names>A.K.</given-names></name></person-group><article-title>miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma</article-title><source>J. Investig. Dermatol.</source><year>2009</year><volume>129</volume><fpage>1740</fpage><lpage>1751</lpage><pub-id pub-id-type="doi">10.1038/jid.2008.452</pub-id><?supplied-pmid 19212343?><pub-id pub-id-type="pmid">19212343</pub-id></element-citation></ref><ref id="B37-ijms-22-01591"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez</surname><given-names>L.A.</given-names></name></person-group><article-title>Aplicaci&#x000f3;n de microarreglos de cADN para estudiar algunos determinantes moleculares de la supresi&#x000f3;n del crecimiento celular en c&#x000e1;ncer</article-title><source>Biomedica</source><year>2009</year><volume>29</volume></element-citation></ref><ref id="B38-ijms-22-01591"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>J.</given-names></name><name><surname>Matsushime</surname><given-names>H.</given-names></name><name><surname>Hiebert</surname><given-names>S.W.</given-names></name><name><surname>Ewen</surname><given-names>M.E.</given-names></name><name><surname>Sherr</surname><given-names>C.J.</given-names></name></person-group><article-title>Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4</article-title><source>Genes Dev.</source><year>1993</year><volume>7</volume><fpage>331</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1101/gad.7.3.331</pub-id><pub-id pub-id-type="pmid">8449399</pub-id></element-citation></ref><ref id="B39-ijms-22-01591"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bates</surname><given-names>S.</given-names></name><name><surname>Bonetta</surname><given-names>L.</given-names></name><name><surname>MacAllan</surname><given-names>D.</given-names></name><name><surname>Parry</surname><given-names>D.</given-names></name><name><surname>Holder</surname><given-names>A.</given-names></name><name><surname>Dickson</surname><given-names>C.</given-names></name><name><surname>Peters</surname><given-names>G.</given-names></name></person-group><article-title>CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1</article-title><source>Oncogene</source><year>1994</year><volume>9</volume><fpage>71</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">8302605</pub-id></element-citation></ref><ref id="B40-ijms-22-01591"><label>40.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Escobar</surname><given-names>L.M.</given-names></name></person-group><source>Expresi&#x000f3;n Diferencial del gen Rock alfa e Inhibici&#x000f3;n del Crecimiento de C&#x000e9;lulas de Melanoma Humano y Murino Inducido por la Genisteina y la L-Tirosina In Vitro.Tesis de Maestr&#x000ed;a</source><publisher-name>Pontificia Universidad Javeriana</publisher-name><publisher-loc>Bogot&#x000e1;, Colombia</publisher-loc><year>2000</year></element-citation></ref><ref id="B41-ijms-22-01591"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melnikova</surname><given-names>V.O.</given-names></name><name><surname>Bolshakov</surname><given-names>S.V.</given-names></name><name><surname>Walker</surname><given-names>C.</given-names></name><name><surname>Ananthaswamy</surname><given-names>H.N.</given-names></name></person-group><article-title>Genomic alterations in spontaneous and carcinogen-induced murine melanoma cell lines</article-title><source>Oncogene</source><year>2004</year><volume>23</volume><fpage>2347</fpage><lpage>2356</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1207405</pub-id><pub-id pub-id-type="pmid">14743208</pub-id></element-citation></ref><ref id="B42-ijms-22-01591"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>S.Y.</given-names></name><name><surname>Kim</surname><given-names>C.G.</given-names></name><name><surname>Lim</surname><given-names>Y.</given-names></name><name><surname>Lee</surname><given-names>Y.H.</given-names></name></person-group><article-title>The ETS family transcription factor ELK-1 regulates induction of the cell cycle-regulatory gene p21(Waf1/Cip1) and the BAX gene in sodium arsenite-exposed human keratinocyte HaCaT cells</article-title><source>J. Biol. Chem.</source><year>2011</year><volume>286</volume><fpage>26860</fpage><lpage>26872</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.216721</pub-id><?supplied-pmid 21642427?><pub-id pub-id-type="pmid">21642427</pub-id></element-citation></ref><ref id="B43-ijms-22-01591"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serrano</surname><given-names>M.</given-names></name><name><surname>Lin</surname><given-names>A.W.</given-names></name><name><surname>McCurrach</surname><given-names>M.E.</given-names></name><name><surname>Beach</surname><given-names>D.</given-names></name><name><surname>Lowe</surname><given-names>S.W.</given-names></name></person-group><article-title>Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a</article-title><source>Cell</source><year>1997</year><volume>88</volume><fpage>593</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81902-9</pub-id><pub-id pub-id-type="pmid">9054499</pub-id></element-citation></ref><ref id="B44-ijms-22-01591"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charrier-Savournin</surname><given-names>F.B.</given-names></name><name><surname>Chateau</surname><given-names>M.T.</given-names></name><name><surname>Gire</surname><given-names>V.</given-names></name><name><surname>Sedivy</surname><given-names>J.</given-names></name><name><surname>Piette</surname><given-names>J.</given-names></name><name><surname>Dulic</surname><given-names>V.</given-names></name></person-group><article-title>p21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress</article-title><source>Mol. Biol. Cell</source><year>2004</year><volume>15</volume><fpage>3965</fpage><lpage>3976</lpage><pub-id pub-id-type="doi">10.1091/mbc.e03-12-0871</pub-id><?supplied-pmid 15181148?><pub-id pub-id-type="pmid">15181148</pub-id></element-citation></ref><ref id="B45-ijms-22-01591"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bunz</surname><given-names>F.</given-names></name><name><surname>Dutriaux</surname><given-names>A.</given-names></name><name><surname>Lengauer</surname><given-names>C.</given-names></name><name><surname>Waldman</surname><given-names>T.</given-names></name><name><surname>Zhou</surname><given-names>S.</given-names></name><name><surname>Brown</surname><given-names>J.P.</given-names></name><name><surname>Sedivy</surname><given-names>J.M.</given-names></name><name><surname>Kinzler</surname><given-names>K.W.</given-names></name><name><surname>Vogelstein</surname><given-names>B.</given-names></name></person-group><article-title>Requirement for p53 and p21 to sustain G2 arrest after DNA damage</article-title><source>Science</source><year>1998</year><volume>282</volume><fpage>1497</fpage><lpage>1501</lpage><pub-id pub-id-type="doi">10.1126/science.282.5393.1497</pub-id><?supplied-pmid 9822382?><pub-id pub-id-type="pmid">9822382</pub-id></element-citation></ref><ref id="B46-ijms-22-01591"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>I.</given-names></name><name><surname>Draetta</surname><given-names>G.</given-names></name><name><surname>Karsenti</surname><given-names>E.</given-names></name></person-group><article-title>Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition</article-title><source>EMBO J.</source><year>1994</year><volume>13</volume><fpage>4302</fpage><lpage>4310</lpage><pub-id pub-id-type="doi">10.1002/j.1460-2075.1994.tb06750.x</pub-id><?supplied-pmid 7523110?><pub-id pub-id-type="pmid">7523110</pub-id></element-citation></ref><ref id="B47-ijms-22-01591"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stead</surname><given-names>E.</given-names></name><name><surname>White</surname><given-names>J.</given-names></name><name><surname>Faast</surname><given-names>R.</given-names></name><name><surname>Conn</surname><given-names>S.</given-names></name><name><surname>Goldstone</surname><given-names>S.</given-names></name><name><surname>Rathjen</surname><given-names>J.</given-names></name><name><surname>Dhingra</surname><given-names>U.</given-names></name><name><surname>Rathjen</surname><given-names>P.</given-names></name><name><surname>Walker</surname><given-names>D.</given-names></name><name><surname>Dalton</surname><given-names>S.</given-names></name></person-group><article-title>Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities</article-title><source>Oncogene</source><year>2002</year><volume>21</volume><fpage>8320</fpage><lpage>8333</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1206015</pub-id><pub-id pub-id-type="pmid">12447695</pub-id></element-citation></ref><ref id="B48-ijms-22-01591"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirobe</surname><given-names>T.</given-names></name><name><surname>Ishikawa</surname><given-names>A.</given-names></name></person-group><article-title>l-tyrosine induces melanocyte differentiation in novel pink-eyed dilution castaneus mouse mutant showing age-related pigmentation</article-title><source>J. Dermatol. Sci.</source><year>2015</year><volume>80</volume><fpage>203</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1016/j.jdermsci.2015.10.002</pub-id><pub-id pub-id-type="pmid">26475433</pub-id></element-citation></ref><ref id="B49-ijms-22-01591"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirobe</surname><given-names>T.</given-names></name><name><surname>Wakamatsu</surname><given-names>K.</given-names></name><name><surname>Ito</surname><given-names>S.</given-names></name><name><surname>Abe</surname><given-names>H.</given-names></name><name><surname>Kawa</surname><given-names>Y.</given-names></name><name><surname>Mizoguchi</surname><given-names>M.</given-names></name></person-group><article-title>Stimulation of the proliferation and differentiation of mouse pink-eyed dilution epidermal melanocytes by excess tyrosine in serum-free primary culture</article-title><source>J. Cell Physiol.</source><year>2002</year><volume>191</volume><fpage>162</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1002/jcp.10085</pub-id><pub-id pub-id-type="pmid">12064459</pub-id></element-citation></ref><ref id="B50-ijms-22-01591"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strasberg Rieber</surname><given-names>M.</given-names></name><name><surname>Welch</surname><given-names>D.R.</given-names></name><name><surname>Miele</surname><given-names>M.E.</given-names></name><name><surname>Rieber</surname><given-names>M.</given-names></name></person-group><article-title>p53-independent increase in p21WAF1 and reciprocal down-regulation of cyclin A and proliferating cell nuclear antigen in bromodeoxyuridine-mediated growth arrest of human melanoma cells</article-title><source>Cell Growth Differ.</source><year>1996</year><volume>7</volume><fpage>197</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">8822203</pub-id></element-citation></ref><ref id="B51-ijms-22-01591"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rieber</surname><given-names>M.</given-names></name><name><surname>Rieber</surname><given-names>M.S.</given-names></name></person-group><article-title>Sensitization to radiation-induced DNA damage accelerates loss of bcl-2 and increases apoptosis and autophagy</article-title><source>Cancer Biol. Ther.</source><year>2008</year><volume>7</volume><fpage>1561</fpage><lpage>1566</lpage><pub-id pub-id-type="doi">10.4161/cbt.7.10.6540</pub-id><pub-id pub-id-type="pmid">18769121</pub-id></element-citation></ref><ref id="B52-ijms-22-01591"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicetto</surname><given-names>D.</given-names></name><name><surname>Zaret</surname><given-names>K.S.</given-names></name></person-group><article-title>Role of H3K9me3 heterochromatin in cell identity establishment and maintenance</article-title><source>Curr. Opin. Genet. Dev.</source><year>2019</year><volume>55</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.gde.2019.04.013</pub-id><pub-id pub-id-type="pmid">31103921</pub-id></element-citation></ref><ref id="B53-ijms-22-01591"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Schleich</surname><given-names>K.</given-names></name><name><surname>Yue</surname><given-names>B.</given-names></name><name><surname>Ji</surname><given-names>S.</given-names></name><name><surname>Lohneis</surname><given-names>P.</given-names></name><name><surname>Kemper</surname><given-names>K.</given-names></name><name><surname>Silvis</surname><given-names>M.R.</given-names></name><name><surname>Qutob</surname><given-names>N.</given-names></name><name><surname>van Rooijen</surname><given-names>E.</given-names></name><name><surname>Werner-Klein</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma</article-title><source>Cancer Cell</source><year>2018</year><volume>33</volume><fpage>322</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2018.01.002</pub-id><pub-id pub-id-type="pmid">29438700</pub-id></element-citation></ref><ref id="B54-ijms-22-01591"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morasso</surname><given-names>M.I.</given-names></name><name><surname>Rieber</surname><given-names>M.S.</given-names></name><name><surname>Gil</surname><given-names>F.</given-names></name><name><surname>Rieber</surname><given-names>M.</given-names></name></person-group><article-title>Cell adhesion regulates melanoma specific differentiation and interactions with the 3&#x02032; region of the tyrosinase gene</article-title><source>Biochem. Biophys. Res. Commun.</source><year>1990</year><volume>172</volume><fpage>638</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1016/0006-291X(90)90722-Y</pub-id><pub-id pub-id-type="pmid">2122896</pub-id></element-citation></ref><ref id="B55-ijms-22-01591"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slominski</surname><given-names>A.</given-names></name></person-group><article-title>L-tyrosine induces synthesis of melanogenesis related proteins</article-title><source>Life Sci.</source><year>1989</year><volume>45</volume><fpage>1799</fpage><lpage>1803</lpage><pub-id pub-id-type="doi">10.1016/0024-3205(89)90520-1</pub-id><pub-id pub-id-type="pmid">2574401</pub-id></element-citation></ref><ref id="B56-ijms-22-01591"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glud</surname><given-names>M.</given-names></name><name><surname>Rossing</surname><given-names>M.</given-names></name><name><surname>Hother</surname><given-names>C.</given-names></name><name><surname>Holst</surname><given-names>L.</given-names></name><name><surname>Hastrup</surname><given-names>N.</given-names></name><name><surname>Nielsen</surname><given-names>F.C.</given-names></name><name><surname>Gniadecki</surname><given-names>R.</given-names></name><name><surname>Drzewiecki</surname><given-names>K.T.</given-names></name></person-group><article-title>Downregulation of miR-125b in metastatic cutaneous malignant melanoma</article-title><source>Melanoma Res.</source><year>2010</year><volume>20</volume><fpage>479</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1097/CMR.0b013e32833e32a1</pub-id><?supplied-pmid 20827223?><pub-id pub-id-type="pmid">20827223</pub-id></element-citation></ref><ref id="B57-ijms-22-01591"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kozubek</surname><given-names>J.</given-names></name><name><surname>Ma</surname><given-names>Z.</given-names></name><name><surname>Fleming</surname><given-names>E.</given-names></name><name><surname>Duggan</surname><given-names>T.</given-names></name><name><surname>Wu</surname><given-names>R.</given-names></name><name><surname>Shin</surname><given-names>D.G.</given-names></name><name><surname>Dadras</surname><given-names>S.S.</given-names></name></person-group><article-title>In-depth characterization of microRNA transcriptome in melanoma</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e72699</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0072699</pub-id><?supplied-pmid 24023765?><pub-id pub-id-type="pmid">24023765</pub-id></element-citation></ref><ref id="B58-ijms-22-01591"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Tetzlaff</surname><given-names>M.T.</given-names></name><name><surname>Liu</surname><given-names>A.</given-names></name><name><surname>Liegl-Atzwanger</surname><given-names>B.</given-names></name><name><surname>Guo</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name></person-group><article-title>Loss of microRNA-205 expression is associated with melanoma progression</article-title><source>Lab. Investig.</source><year>2012</year><volume>92</volume><fpage>1084</fpage><lpage>1096</lpage><pub-id pub-id-type="doi">10.1038/labinvest.2012.62</pub-id><?supplied-pmid 22525428?><pub-id pub-id-type="pmid">22525428</pub-id></element-citation></ref><ref id="B59-ijms-22-01591"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schultz</surname><given-names>J.</given-names></name><name><surname>Lorenz</surname><given-names>P.</given-names></name><name><surname>Gross</surname><given-names>G.</given-names></name><name><surname>Ibrahim</surname><given-names>S.</given-names></name><name><surname>Kunz</surname><given-names>M.</given-names></name></person-group><article-title>MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth</article-title><source>Cell Res.</source><year>2008</year><volume>18</volume><fpage>549</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1038/cr.2008.45</pub-id><?supplied-pmid 18379589?><pub-id pub-id-type="pmid">18379589</pub-id></element-citation></ref><ref id="B60-ijms-22-01591"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sand</surname><given-names>M.</given-names></name><name><surname>Skrygan</surname><given-names>M.</given-names></name><name><surname>Sand</surname><given-names>D.</given-names></name><name><surname>Georgas</surname><given-names>D.</given-names></name><name><surname>Gambichler</surname><given-names>T.</given-names></name><name><surname>Hahn</surname><given-names>S.A.</given-names></name><name><surname>Altmeyer</surname><given-names>P.</given-names></name><name><surname>Bechara</surname><given-names>F.G.</given-names></name></person-group><article-title>Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi</article-title><source>Cell Tissue Res.</source><year>2013</year><volume>351</volume><fpage>85</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1007/s00441-012-1514-5</pub-id><pub-id pub-id-type="pmid">23111773</pub-id></element-citation></ref><ref id="B61-ijms-22-01591"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diermeier</surname><given-names>S.</given-names></name><name><surname>Schmidt-Bruecken</surname><given-names>E.</given-names></name><name><surname>Kubbies</surname><given-names>M.</given-names></name><name><surname>Kunz-Schughart</surname><given-names>L.A.</given-names></name><name><surname>Brockhoff</surname><given-names>G.</given-names></name></person-group><article-title>Exposure to continuous bromodeoxyuridine (BrdU) differentially affects cell cycle progression of human breast and bladder cancer cell lines</article-title><source>Cell Prolif.</source><year>2004</year><volume>37</volume><fpage>195</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2184.2004.00296.x</pub-id><pub-id pub-id-type="pmid">15030553</pub-id></element-citation></ref><ref id="B62-ijms-22-01591"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michishita</surname><given-names>E.</given-names></name><name><surname>Nakabayashi</surname><given-names>K.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Kaul</surname><given-names>S.C.</given-names></name><name><surname>Ogino</surname><given-names>H.</given-names></name><name><surname>Fujii</surname><given-names>M.</given-names></name><name><surname>Mitsui</surname><given-names>Y.</given-names></name><name><surname>Ayusawa</surname><given-names>D.</given-names></name></person-group><article-title>5-Bromodeoxyuridine induces senescence-like phenomena in mammalian cells regardless of cell type or species</article-title><source>J. Biochem.</source><year>1999</year><volume>126</volume><fpage>1052</fpage><lpage>1059</lpage><pub-id pub-id-type="pmid">10578056</pub-id></element-citation></ref><ref id="B63-ijms-22-01591"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silagi</surname><given-names>S.</given-names></name></person-group><article-title>Effects of 5-bromodeoxyuridine on tumorigenicity, immunogenicity, virus production, plasminogen activator, and melanogenesis of mouse melanoma cells</article-title><source>Int. Rev. Cytol.</source><year>1976</year><volume>45</volume><fpage>65</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">821894</pub-id></element-citation></ref><ref id="B64-ijms-22-01591"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>L.</given-names></name><name><surname>Chan</surname><given-names>P.W.</given-names></name><name><surname>Chang</surname><given-names>S.</given-names></name><name><surname>Damsky</surname><given-names>C.</given-names></name></person-group><article-title>5-Bromo-2-deoxyuridine regulates invasiveness and expression of integrins and matrix-degrading proteinases in a differentiated hamster melanoma cell</article-title><source>J. Cell. Sci.</source><year>1993</year><volume>105</volume><fpage>191</fpage><lpage>201</lpage><?supplied-pmid 8360273?><pub-id pub-id-type="pmid">8360273</pub-id></element-citation></ref><ref id="B65-ijms-22-01591"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rauth</surname><given-names>S.</given-names></name><name><surname>Davidson</surname><given-names>R.L.</given-names></name></person-group><article-title>Suppression of tyrosinase gene expression by bromodeoxyuridine in Syrian hamster melanoma cells is not due to its incorporation into upstream or coding sequences of the tyrosinase gene</article-title><source>Somat. Cell Mol. Genet</source><year>1993</year><volume>19</volume><fpage>285</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1007/BF01233076</pub-id><?supplied-pmid 8332936?><pub-id pub-id-type="pmid">8332936</pub-id></element-citation></ref><ref id="B66-ijms-22-01591"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slominski</surname><given-names>A.</given-names></name><name><surname>Paus</surname><given-names>R.</given-names></name></person-group><article-title>Are L-tyrosine and L-dopa hormone-like bioregulators?</article-title><source>J. Theor. Biol.</source><year>1990</year><volume>143</volume><fpage>123</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1016/S0022-5193(05)80292-9</pub-id><pub-id pub-id-type="pmid">2359315</pub-id></element-citation></ref><ref id="B67-ijms-22-01591"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slominski</surname><given-names>A.</given-names></name><name><surname>Zmijewski</surname><given-names>M.A.</given-names></name><name><surname>Pawelek</surname><given-names>J.</given-names></name></person-group><article-title>L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions</article-title><source>Pigment Cell Melanoma Res.</source><year>2012</year><volume>25</volume><fpage>14</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1111/j.1755-148X.2011.00898.x</pub-id><?supplied-pmid 21834848?><pub-id pub-id-type="pmid">21834848</pub-id></element-citation></ref><ref id="B68-ijms-22-01591"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solano</surname><given-names>F.</given-names></name></person-group><article-title>Melanins: Skin Pigments and Much More&#x02014;Types, Structural Models, Biological Functions, and Formation Routes</article-title><source>New J. Sci.</source><year>2014</year><volume>2014</volume><fpage>498276</fpage><pub-id pub-id-type="doi">10.1155/2014/498276</pub-id></element-citation></ref><ref id="B69-ijms-22-01591"><label>69.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gunturiz</surname><given-names>M.L.</given-names></name><name><surname>G&#x000f3;mez</surname><given-names>L.A.</given-names></name></person-group><source>Expresi&#x000f3;n de Los Genes Que Regulan La S&#x000ed;ntesis de Melanina: MITF-M, TRP1 y TRP2 En C&#x000e9;lulas de Melanoma Maligno B16 y A375</source><publisher-name>Instituto Nacional de Salud</publisher-name><publisher-loc>Bogot&#x000e1;, Colombia</publisher-loc><year>2013</year><fpage>51</fpage></element-citation></ref><ref id="B70-ijms-22-01591"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rauth</surname><given-names>S.</given-names></name><name><surname>Hoganson</surname><given-names>G.E.</given-names></name><name><surname>Davidson</surname><given-names>R.L.</given-names></name></person-group><article-title>Bromodeoxyuridine- and cyclic AMP-mediated regulation of tyrosinase in Syrian hamster melanoma cells</article-title><source>Somat. Cell Mol. Genet.</source><year>1990</year><volume>16</volume><fpage>583</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1007/BF01233099</pub-id><pub-id pub-id-type="pmid">2176354</pub-id></element-citation></ref><ref id="B71-ijms-22-01591"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haflidadottir</surname><given-names>B.S.</given-names></name><name><surname>Bergsteinsdottir</surname><given-names>K.</given-names></name><name><surname>Praetorius</surname><given-names>C.</given-names></name><name><surname>Steingrimsson</surname><given-names>E.</given-names></name></person-group><article-title>miR-148 regulates Mitf in melanoma cells</article-title><source>PLoS ONE</source><year>2010</year><volume>5</volume><elocation-id>e11574</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0011574</pub-id><pub-id pub-id-type="pmid">20644734</pub-id></element-citation></ref><ref id="B72-ijms-22-01591"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Git</surname><given-names>A.</given-names></name><name><surname>Dvinge</surname><given-names>H.</given-names></name><name><surname>Salmon-Divon</surname><given-names>M.</given-names></name><name><surname>Osborne</surname><given-names>M.</given-names></name><name><surname>Kutter</surname><given-names>C.</given-names></name><name><surname>Hadfield</surname><given-names>J.</given-names></name><name><surname>Bertone</surname><given-names>P.</given-names></name><name><surname>Caldas</surname><given-names>C.</given-names></name></person-group><article-title>Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression</article-title><source>RNA</source><year>2010</year><volume>16</volume><fpage>991</fpage><lpage>1006</lpage><pub-id pub-id-type="doi">10.1261/rna.1947110</pub-id><pub-id pub-id-type="pmid">20360395</pub-id></element-citation></ref><ref id="B73-ijms-22-01591"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Ridzon</surname><given-names>D.A.</given-names></name><name><surname>Broomer</surname><given-names>A.J.</given-names></name><name><surname>Zhou</surname><given-names>Z.</given-names></name><name><surname>Lee</surname><given-names>D.H.</given-names></name><name><surname>Nguyen</surname><given-names>J.T.</given-names></name><name><surname>Barbisin</surname><given-names>M.</given-names></name><name><surname>Xu</surname><given-names>N.L.</given-names></name><name><surname>Mahuvakar</surname><given-names>V.R.</given-names></name><name><surname>Andersen</surname><given-names>M.R.</given-names></name><etal/></person-group><article-title>Real-time quantification of microRNAs by stem-loop RT-PCR</article-title><source>Nucleic Acids Res.</source><year>2005</year><volume>33</volume><fpage>e179</fpage><pub-id pub-id-type="doi">10.1093/nar/gni178</pub-id><pub-id pub-id-type="pmid">16314309</pub-id></element-citation></ref><ref id="B74-ijms-22-01591"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tay</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Thomson</surname><given-names>A.M.</given-names></name><name><surname>Lim</surname><given-names>B.</given-names></name><name><surname>Rigoutsos</surname><given-names>I.</given-names></name></person-group><article-title>MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation</article-title><source>Nature</source><year>2008</year><volume>455</volume><fpage>1124</fpage><lpage>1128</lpage><pub-id pub-id-type="doi">10.1038/nature07299</pub-id><pub-id pub-id-type="pmid">18806776</pub-id></element-citation></ref><ref id="B75-ijms-22-01591"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Qian</surname><given-names>N.</given-names></name><name><surname>Tao</surname><given-names>K.</given-names></name><name><surname>You</surname><given-names>N.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Dou</surname><given-names>K.</given-names></name></person-group><article-title>MicroRNAs involved in neoplastic transformation of liver cancer stem cells</article-title><source>J. Exp. Clin. Cancer Res.</source><year>2010</year><volume>29</volume><fpage>169</fpage><pub-id pub-id-type="doi">10.1186/1756-9966-29-169</pub-id><pub-id pub-id-type="pmid">21176238</pub-id></element-citation></ref><ref id="B76-ijms-22-01591"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tam</surname><given-names>S.W.</given-names></name><name><surname>Theodoras</surname><given-names>A.M.</given-names></name><name><surname>Shay</surname><given-names>J.W.</given-names></name><name><surname>Draetta</surname><given-names>G.F.</given-names></name><name><surname>Pagano</surname><given-names>M.</given-names></name></person-group><article-title>Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: Association with Cdk4 is required for Cyclin D1 function in G1 progression</article-title><source>Oncogene</source><year>1994</year><volume>9</volume><fpage>2663</fpage><lpage>2674</lpage><pub-id pub-id-type="pmid">8058330</pub-id></element-citation></ref><ref id="B77-ijms-22-01591"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couts</surname><given-names>K.L.</given-names></name><name><surname>Anderson</surname><given-names>E.M.</given-names></name><name><surname>Gross</surname><given-names>M.M.</given-names></name><name><surname>Sullivan</surname><given-names>K.</given-names></name><name><surname>Ahn</surname><given-names>N.G.</given-names></name></person-group><article-title>Oncogenic B-Raf signaling in melanoma cells controls a network of microRNAs with combinatorial functions</article-title><source>Oncogene</source><year>2013</year><volume>32</volume><fpage>1959</fpage><lpage>1970</lpage><pub-id pub-id-type="doi">10.1038/onc.2012.209</pub-id><pub-id pub-id-type="pmid">22751131</pub-id></element-citation></ref><ref id="B78-ijms-22-01591"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Feilotter</surname><given-names>H.E.</given-names></name><name><surname>Pare</surname><given-names>G.C.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Pemberton</surname><given-names>J.G.</given-names></name><name><surname>Garady</surname><given-names>C.</given-names></name><name><surname>Lai</surname><given-names>D.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Tron</surname><given-names>V.A.</given-names></name></person-group><article-title>MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma</article-title><source>Am. J. Pathol.</source><year>2010</year><volume>176</volume><fpage>2520</fpage><lpage>2529</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2010.091061</pub-id><?supplied-pmid 20304954?><pub-id pub-id-type="pmid">20304954</pub-id></element-citation></ref><ref id="B79-ijms-22-01591"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>D.W.</given-names></name><name><surname>Bosserhoff</surname><given-names>A.K.</given-names></name></person-group><article-title>Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma</article-title><source>Oncogene</source><year>2008</year><volume>27</volume><fpage>6698</fpage><lpage>6706</lpage><pub-id pub-id-type="doi">10.1038/onc.2008.282</pub-id><?supplied-pmid 18679415?><pub-id pub-id-type="pmid">18679415</pub-id></element-citation></ref><ref id="B80-ijms-22-01591"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Ma</surname><given-names>P.</given-names></name><name><surname>Jing</surname><given-names>Y.</given-names></name><name><surname>Peng</surname><given-names>H.</given-names></name><name><surname>Gao</surname><given-names>W.-Q.</given-names></name><name><surname>Zhuang</surname><given-names>G.</given-names></name></person-group><article-title>Lin28B promotes melanoma growth by mediating a microRNA regulatory circuit</article-title><source>Carcinogenesis</source><year>2015</year><volume>36</volume><fpage>937</fpage><lpage>945</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgv085</pub-id><?supplied-pmid 26071398?><pub-id pub-id-type="pmid">26071398</pub-id></element-citation></ref><ref id="B81-ijms-22-01591"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>T.Y.</given-names></name><name><surname>Chang</surname><given-names>C.C.</given-names></name><name><surname>Lin</surname><given-names>C.T.</given-names></name><name><surname>Lai</surname><given-names>C.H.</given-names></name><name><surname>Peng</surname><given-names>S.Y.</given-names></name><name><surname>Ko</surname><given-names>Y.J.</given-names></name><name><surname>Tang</surname><given-names>P.C.</given-names></name></person-group><article-title>Let-7b-mediated suppression of basigin expression and metastasis in mouse melanoma cells</article-title><source>Exp. Cell Res.</source><year>2011</year><volume>317</volume><fpage>445</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2010.11.004</pub-id><?supplied-pmid 21087605?><pub-id pub-id-type="pmid">21087605</pub-id></element-citation></ref><ref id="B82-ijms-22-01591"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serguienko</surname><given-names>A.</given-names></name><name><surname>Grad</surname><given-names>I.</given-names></name><name><surname>Wennerstrom</surname><given-names>A.B.</given-names></name><name><surname>Meza-Zepeda</surname><given-names>L.A.</given-names></name><name><surname>Thiede</surname><given-names>B.</given-names></name><name><surname>Stratford</surname><given-names>E.W.</given-names></name><name><surname>Myklebost</surname><given-names>O.</given-names></name><name><surname>Munthe</surname><given-names>E.</given-names></name></person-group><article-title>Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA</article-title><source>Oncotarget</source><year>2015</year><volume>6</volume><fpage>2451</fpage><lpage>2465</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.3235</pub-id><pub-id pub-id-type="pmid">25669981</pub-id></element-citation></ref><ref id="B83-ijms-22-01591"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>J.</given-names></name><name><surname>Menggen</surname><given-names>Q.</given-names></name><name><surname>Wuren</surname><given-names>Q.</given-names></name><name><surname>Shi</surname><given-names>Q.</given-names></name><name><surname>Pi</surname><given-names>X.</given-names></name></person-group><article-title>Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) Promotes Tumor Growth and Metastasis through TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) Axis in Malignant Melanoma</article-title><source>Med. Sci. Monit.</source><year>2018</year><volume>24</volume><fpage>1547</fpage><lpage>1559</lpage><pub-id pub-id-type="doi">10.12659/MSM.906616</pub-id><pub-id pub-id-type="pmid">29543785</pub-id></element-citation></ref><ref id="B84-ijms-22-01591"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>X.</given-names></name><name><surname>Kong</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>Q.</given-names></name><name><surname>Yin</surname><given-names>Q.</given-names></name><name><surname>Cong</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Ju</surname><given-names>S.</given-names></name></person-group><article-title>PCAT-1 promotes cell growth by sponging miR-129 via MAP3K7/NF-kappaB pathway in multiple myeloma</article-title><source>J. Cell Mol. Med.</source><year>2020</year><pub-id pub-id-type="doi">10.1111/jcmm.15035</pub-id></element-citation></ref><ref id="B85-ijms-22-01591"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diao</surname><given-names>Y.</given-names></name><name><surname>Jin</surname><given-names>B.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name></person-group><article-title>MiR-129-5p inhibits glioma cell progression in vitro and in vivo by targeting TGIF2</article-title><source>J. Cell Mol. Med.</source><year>2018</year><volume>22</volume><fpage>2357</fpage><lpage>2367</lpage><pub-id pub-id-type="doi">10.1111/jcmm.13529</pub-id><?supplied-pmid 29431269?><pub-id pub-id-type="pmid">29431269</pub-id></element-citation></ref><ref id="B86-ijms-22-01591"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>A.</given-names></name><name><surname>Yin</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Jin</surname><given-names>X.</given-names></name><name><surname>Shen</surname><given-names>F.</given-names></name><name><surname>Yan</surname><given-names>W.</given-names></name><name><surname>You</surname><given-names>Y.</given-names></name></person-group><article-title>miR-129-5p targets Wnt5a to block PKC/ERK/NF-kappaB and JNK pathways in glioblastoma</article-title><source>Cell Death Dis.</source><year>2018</year><volume>9</volume><fpage>394</fpage><pub-id pub-id-type="doi">10.1038/s41419-018-0343-1</pub-id><?supplied-pmid 29531296?><pub-id pub-id-type="pmid">29531296</pub-id></element-citation></ref><ref id="B87-ijms-22-01591"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Ge</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name></person-group><article-title>MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer</article-title><source>Biomed. Pharmacother.</source><year>2017</year><volume>96</volume><fpage>634</fpage><lpage>641</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2017.10.037</pub-id><?supplied-pmid 29035829?><pub-id pub-id-type="pmid">29035829</pub-id></element-citation></ref><ref id="B88-ijms-22-01591"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>P.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name></person-group><article-title>Inactivation of the Wnt/beta-catenin signaling pathway underlies inhibitory role of microRNA-129-5p in epithelial-mesenchymal transition and angiogenesis of prostate cancer by targeting ZIC2</article-title><source>Cancer Cell Int.</source><year>2019</year><volume>19</volume><fpage>271</fpage><pub-id pub-id-type="doi">10.1186/s12935-019-0977-9</pub-id><pub-id pub-id-type="pmid">31649488</pub-id></element-citation></ref><ref id="B89-ijms-22-01591"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ya</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>A.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name></person-group><article-title>Serum miR-129 functions as a biomarker for colorectal cancer by targeting estrogen receptor (ER) beta</article-title><source>Pharmazie</source><year>2017</year><volume>72</volume><fpage>107</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1691/ph.2017.6718</pub-id><pub-id pub-id-type="pmid">29441863</pub-id></element-citation></ref><ref id="B90-ijms-22-01591"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Setijono</surname><given-names>S.R.</given-names></name><name><surname>Park</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>G.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Cho</surname><given-names>K.W.</given-names></name><name><surname>Song</surname><given-names>S.J.</given-names></name></person-group><article-title>miR-218 and miR-129 regulate breast cancer progression by targeting Lamins</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2018</year><volume>496</volume><fpage>826</fpage><lpage>833</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2018.01.146</pub-id><pub-id pub-id-type="pmid">29378184</pub-id></element-citation></ref><ref id="B91-ijms-22-01591"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>J.J.</given-names></name><name><surname>Lin</surname><given-names>J.</given-names></name><name><surname>Zhu</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Brooks</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Chu</surname><given-names>Z.B.</given-names></name><name><surname>Takada</surname><given-names>K.</given-names></name><name><surname>Ciccarelli</surname><given-names>B.</given-names></name><name><surname>Admin</surname><given-names>S.</given-names></name><etal/></person-group><article-title>miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/beta-catenin/BCL9 pathway</article-title><source>Cancer Res.</source><year>2014</year><volume>74</volume><fpage>1801</fpage><lpage>1813</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-13-3311-T</pub-id><pub-id pub-id-type="pmid">24599134</pub-id></element-citation></ref><ref id="B92-ijms-22-01591"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ouzounova</surname><given-names>M.</given-names></name><name><surname>Vuong</surname><given-names>T.</given-names></name><name><surname>Ancey</surname><given-names>P.B.</given-names></name><name><surname>Ferrand</surname><given-names>M.</given-names></name><name><surname>Durand</surname><given-names>G.</given-names></name><name><surname>Le-Calvez Kelm</surname><given-names>F.</given-names></name><name><surname>Croce</surname><given-names>C.</given-names></name><name><surname>Matar</surname><given-names>C.</given-names></name><name><surname>Herceg</surname><given-names>Z.</given-names></name><name><surname>Hernandez-Vargas</surname><given-names>H.</given-names></name></person-group><article-title>MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells</article-title><source>BMC Genom.</source><year>2013</year><volume>14</volume><elocation-id>139</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2164-14-139</pub-id></element-citation></ref><ref id="B93-ijms-22-01591"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Bai</surname><given-names>J.</given-names></name></person-group><article-title>Mir-30d suppresses cell proliferation of colon cancer cells by inhibiting cell autophagy and promoting cell apoptosis</article-title><source>Tumour. Biol.</source><year>2017</year><volume>39</volume><pub-id pub-id-type="doi">10.1177/1010428317703984</pub-id></element-citation></ref><ref id="B94-ijms-22-01591"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Donath</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Qin</surname><given-names>D.</given-names></name><name><surname>Prabhakar</surname><given-names>B.S.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name></person-group><article-title>miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway</article-title><source>PLoS Genet.</source><year>2010</year><volume>6</volume><elocation-id>e1000795</elocation-id><pub-id pub-id-type="doi">10.1371/annotation/4050116d-8daa-4b5a-99e9-34cdd13f6a26</pub-id><pub-id pub-id-type="pmid">20062521</pub-id></element-citation></ref><ref id="B95-ijms-22-01591"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Jin</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Zhuo</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Gong</surname><given-names>K.</given-names></name><name><surname>Mao</surname><given-names>Z.</given-names></name></person-group><article-title>MiR-30d induces apoptosis and is regulated by the Akt/FOXO pathway in renal cell carcinoma</article-title><source>Cell Signal</source><year>2013</year><volume>25</volume><fpage>1212</fpage><lpage>1221</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2013.01.028</pub-id><?supplied-pmid 23416459?><pub-id pub-id-type="pmid">23416459</pub-id></element-citation></ref><ref id="B96-ijms-22-01591"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>I.</given-names></name><name><surname>Cazalla</surname><given-names>D.</given-names></name><name><surname>Almstead</surname><given-names>L.L.</given-names></name><name><surname>Steitz</surname><given-names>J.A.</given-names></name><name><surname>DiMaio</surname><given-names>D.</given-names></name></person-group><article-title>miR-29 and miR-30 regulate B-Myb expression during cellular senescence</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2011</year><volume>108</volume><fpage>522</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1073/pnas.1017346108</pub-id><?supplied-pmid 21187425?><pub-id pub-id-type="pmid">21187425</pub-id></element-citation></ref><ref id="B97-ijms-22-01591"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>W.</given-names></name><name><surname>Hong</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>S.</given-names></name><name><surname>Herpai</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Truong</surname><given-names>L.</given-names></name><name><surname>Hu</surname><given-names>W.Y.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><etal/></person-group><article-title>miR-30 disrupts senescence and promotes cancer by targeting both p16(INK4A) and DNA damage pathways</article-title><source>Oncogene</source><year>2018</year><volume>37</volume><fpage>5618</fpage><lpage>5632</lpage><pub-id pub-id-type="doi">10.1038/s41388-018-0358-1</pub-id><?supplied-pmid 29907771?><pub-id pub-id-type="pmid">29907771</pub-id></element-citation></ref><ref id="B98-ijms-22-01591"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaziel-Sovran</surname><given-names>A.</given-names></name><name><surname>Segura</surname><given-names>M.F.</given-names></name><name><surname>Di Micco</surname><given-names>R.</given-names></name><name><surname>Collins</surname><given-names>M.K.</given-names></name><name><surname>Hanniford</surname><given-names>D.</given-names></name><name><surname>Vega-Saenz de Miera</surname><given-names>E.</given-names></name><name><surname>Rakus</surname><given-names>J.F.</given-names></name><name><surname>Dankert</surname><given-names>J.F.</given-names></name><name><surname>Shang</surname><given-names>S.</given-names></name><name><surname>Kerbel</surname><given-names>R.S.</given-names></name><etal/></person-group><article-title>miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis</article-title><source>Cancer Cell</source><year>2011</year><volume>20</volume><fpage>104</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2011.05.027</pub-id><?supplied-pmid 21741600?><pub-id pub-id-type="pmid">21741600</pub-id></element-citation></ref><ref id="B99-ijms-22-01591"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rieber</surname><given-names>M.S.</given-names></name><name><surname>Rieber</surname><given-names>M.</given-names></name></person-group><article-title>Specific tyrosinases associated with melanoma replicative senescence and melanogenesis</article-title><source>Cancer Res.</source><year>1993</year><volume>53</volume><fpage>2469</fpage><lpage>2471</lpage><?supplied-pmid 8495406?><pub-id pub-id-type="pmid">8495406</pub-id></element-citation></ref><ref id="B100-ijms-22-01591"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sestakova</surname><given-names>B.</given-names></name><name><surname>Ondrusova</surname><given-names>L.</given-names></name><name><surname>Vachtenheim</surname><given-names>J.</given-names></name></person-group><article-title>Cell cycle inhibitor p21/ WAF1/ CIP1 as a cofactor of MITF expression in melanoma cells</article-title><source>Pigment Cell Melanoma Res.</source><year>2010</year><volume>23</volume><fpage>238</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1111/j.1755-148X.2010.00670.x</pub-id><?supplied-pmid 20067556?><pub-id pub-id-type="pmid">20067556</pub-id></element-citation></ref><ref id="B101-ijms-22-01591"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>J.</given-names></name><name><surname>Widlund</surname><given-names>H.R.</given-names></name><name><surname>Horstmann</surname><given-names>M.A.</given-names></name><name><surname>Ramaswamy</surname><given-names>S.</given-names></name><name><surname>Ross</surname><given-names>K.</given-names></name><name><surname>Huber</surname><given-names>W.E.</given-names></name><name><surname>Nishimura</surname><given-names>E.K.</given-names></name><name><surname>Golub</surname><given-names>T.R.</given-names></name><name><surname>Fisher</surname><given-names>D.E.</given-names></name></person-group><article-title>Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF</article-title><source>Cancer Cell</source><year>2004</year><volume>6</volume><fpage>565</fpage><lpage>576</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2004.10.014</pub-id><pub-id pub-id-type="pmid">15607961</pub-id></element-citation></ref><ref id="B102-ijms-22-01591"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haddad</surname><given-names>M.M.</given-names></name><name><surname>Xu</surname><given-names>W.</given-names></name><name><surname>Schwahn</surname><given-names>D.J.</given-names></name><name><surname>Liao</surname><given-names>F.</given-names></name><name><surname>Medrano</surname><given-names>E.E.</given-names></name></person-group><article-title>Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes</article-title><source>Exp. Cell Res.</source><year>1999</year><volume>253</volume><fpage>561</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1006/excr.1999.4688</pub-id><pub-id pub-id-type="pmid">10585280</pub-id></element-citation></ref><ref id="B103-ijms-22-01591"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>X.</given-names></name><name><surname>Rao</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Fan</surname><given-names>L.</given-names></name><name><surname>Geng</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Qu</surname><given-names>J.</given-names></name><name><surname>Hou</surname><given-names>L.</given-names></name></person-group><article-title>Regulation of pigmentation by microRNAs: MITF-dependent microRNA-211 targets TGF-beta receptor 2</article-title><source>Pigment Cell Melanoma Res.</source><year>2015</year><volume>28</volume><fpage>217</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1111/pcmr.12334</pub-id><pub-id pub-id-type="pmid">25444235</pub-id></element-citation></ref><ref id="B104-ijms-22-01591"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vitiello</surname><given-names>M.</given-names></name><name><surname>Tuccoli</surname><given-names>A.</given-names></name><name><surname>D&#x02019;Aurizio</surname><given-names>R.</given-names></name><name><surname>Sarti</surname><given-names>S.</given-names></name><name><surname>Giannecchini</surname><given-names>L.</given-names></name><name><surname>Lubrano</surname><given-names>S.</given-names></name><name><surname>Marranci</surname><given-names>A.</given-names></name><name><surname>Evangelista</surname><given-names>M.</given-names></name><name><surname>Peppicelli</surname><given-names>S.</given-names></name><name><surname>Ippolito</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>25395</fpage><lpage>25417</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.15915</pub-id><pub-id pub-id-type="pmid">28445987</pub-id></element-citation></ref><ref id="B105-ijms-22-01591"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noguchi</surname><given-names>S.</given-names></name><name><surname>Mori</surname><given-names>T.</given-names></name><name><surname>Otsuka</surname><given-names>Y.</given-names></name><name><surname>Yamada</surname><given-names>N.</given-names></name><name><surname>Yasui</surname><given-names>Y.</given-names></name><name><surname>Iwasaki</surname><given-names>J.</given-names></name><name><surname>Kumazaki</surname><given-names>M.</given-names></name><name><surname>Maruo</surname><given-names>K.</given-names></name><name><surname>Akao</surname><given-names>Y.</given-names></name></person-group><article-title>Anti-oncogenic microRNA-203 induces senescence by targeting E2F3 protein in human melanoma cells</article-title><source>J. Biol. Chem.</source><year>2012</year><volume>287</volume><fpage>11769</fpage><lpage>11777</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.325027</pub-id><?supplied-pmid 22354972?><pub-id pub-id-type="pmid">22354972</pub-id></element-citation></ref><ref id="B106-ijms-22-01591"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glud</surname><given-names>M.</given-names></name><name><surname>Manfe</surname><given-names>V.</given-names></name><name><surname>Biskup</surname><given-names>E.</given-names></name><name><surname>Holst</surname><given-names>L.</given-names></name><name><surname>Dirksen</surname><given-names>A.M.</given-names></name><name><surname>Hastrup</surname><given-names>N.</given-names></name><name><surname>Nielsen</surname><given-names>F.C.</given-names></name><name><surname>Drzewiecki</surname><given-names>K.T.</given-names></name><name><surname>Gniadecki</surname><given-names>R.</given-names></name></person-group><article-title>MicroRNA miR-125b induces senescence in human melanoma cells</article-title><source>Melanoma Res.</source><year>2011</year><volume>21</volume><fpage>253</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1097/CMR.0b013e328345333b</pub-id><?supplied-pmid 21460750?><pub-id pub-id-type="pmid">21460750</pub-id></element-citation></ref><ref id="B107-ijms-22-01591"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dar</surname><given-names>A.A.</given-names></name><name><surname>Majid</surname><given-names>S.</given-names></name><name><surname>de Semir</surname><given-names>D.</given-names></name><name><surname>Nosrati</surname><given-names>M.</given-names></name><name><surname>Bezrookove</surname><given-names>V.</given-names></name><name><surname>Kashani-Sabet</surname><given-names>M.</given-names></name></person-group><article-title>miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein</article-title><source>J. Biol. Chem.</source><year>2011</year><volume>286</volume><fpage>16606</fpage><lpage>16614</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.227611</pub-id><?supplied-pmid 21454583?><pub-id pub-id-type="pmid">21454583</pub-id></element-citation></ref><ref id="B108-ijms-22-01591"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fattore</surname><given-names>L.</given-names></name><name><surname>Ruggiero</surname><given-names>C.F.</given-names></name><name><surname>Pisanu</surname><given-names>M.E.</given-names></name><name><surname>Liguoro</surname><given-names>D.</given-names></name><name><surname>Cerri</surname><given-names>A.</given-names></name><name><surname>Costantini</surname><given-names>S.</given-names></name><name><surname>Capone</surname><given-names>F.</given-names></name><name><surname>Acunzo</surname><given-names>M.</given-names></name><name><surname>Romano</surname><given-names>G.</given-names></name><name><surname>Nigita</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma</article-title><source>Cell Death Differ.</source><year>2019</year><volume>26</volume><fpage>1267</fpage><lpage>1282</lpage><pub-id pub-id-type="doi">10.1038/s41418-018-0205-5</pub-id><?supplied-pmid 30254376?><pub-id pub-id-type="pmid">30254376</pub-id></element-citation></ref><ref id="B109-ijms-22-01591"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname><given-names>M.K.</given-names></name></person-group><article-title>Measurement of growth and viability of cells in culture</article-title><source>Methods Enzymol.</source><year>1979</year><volume>11</volume><fpage>141</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1016/s0076-6879(79)58132-4</pub-id></element-citation></ref><ref id="B110-ijms-22-01591"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pozarowski</surname><given-names>P.</given-names></name><name><surname>Darzynkiewicz</surname><given-names>Z.</given-names></name></person-group><article-title>Analysis of cell cycle by flow cytometry</article-title><source>Methods Mol. Biol.</source><year>2004</year><volume>281</volume><fpage>301</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1385/1-59259-811-0:301</pub-id><?supplied-pmid 15220539?><pub-id pub-id-type="pmid">15220539</pub-id></element-citation></ref><ref id="B111-ijms-22-01591"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debacq-Chainiaux</surname><given-names>F.</given-names></name><name><surname>Erusalimsky</surname><given-names>J.D.</given-names></name><name><surname>Campisi</surname><given-names>J.</given-names></name><name><surname>Toussaint</surname><given-names>O.</given-names></name></person-group><article-title>Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo</article-title><source>Nat. Protoc.</source><year>2009</year><volume>4</volume><fpage>1798</fpage><lpage>1806</lpage><pub-id pub-id-type="doi">10.1038/nprot.2009.191</pub-id><?supplied-pmid 20010931?><pub-id pub-id-type="pmid">20010931</pub-id></element-citation></ref><ref id="B112-ijms-22-01591"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haycock</surname><given-names>J.W.</given-names></name></person-group><article-title>Polyvinylpyrrolidone as a blocking agent in immunochemical studies</article-title><source>Anal. Biochem.</source><year>1993</year><volume>208</volume><fpage>397</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1006/abio.1993.1068</pub-id><pub-id pub-id-type="pmid">8095775</pub-id></element-citation></ref><ref id="B113-ijms-22-01591"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chomczynski</surname><given-names>P.</given-names></name><name><surname>Sacchi</surname><given-names>N.</given-names></name></person-group><article-title>Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction</article-title><source>Anal. Biochem.</source><year>1987</year><volume>162</volume><fpage>156</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1016/0003-2697(87)90021-2</pub-id><pub-id pub-id-type="pmid">2440339</pub-id></element-citation></ref><ref id="B114-ijms-22-01591"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>B.</given-names></name><name><surname>Kim</surname><given-names>D.S.</given-names></name><name><surname>Deluca</surname><given-names>A.M.</given-names></name><name><surname>Alani</surname><given-names>R.M.</given-names></name></person-group><article-title>Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression</article-title><source>PLoS ONE</source><year>2007</year><volume>2</volume><elocation-id>e594</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0000594</pub-id><pub-id pub-id-type="pmid">17611626</pub-id></element-citation></ref><ref id="B115-ijms-22-01591"><label>115.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Jolliffe</surname><given-names>I.</given-names></name></person-group><article-title>Principal Component Analysis</article-title><source>Wiley StatsRef: Statistics Reference Online</source><publisher-name>John Wiley &#x00026; Sons, Ltd.</publisher-name><publisher-loc>Hoboken, NJ, USA</publisher-loc><year>2014</year><pub-id pub-id-type="doi">10.1002/9781118445112.stat06472</pub-id></element-citation></ref><ref id="B116-ijms-22-01591"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anders</surname><given-names>S.</given-names></name><name><surname>Huber</surname><given-names>W.</given-names></name></person-group><article-title>Differential expression analysis for sequence count data</article-title><source>Genome Biol.</source><year>2010</year><volume>11</volume><fpage>R106</fpage><pub-id pub-id-type="doi">10.1186/gb-2010-11-10-r106</pub-id><?supplied-pmid 20979621?><pub-id pub-id-type="pmid">20979621</pub-id></element-citation></ref><ref id="B117-ijms-22-01591"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>M.I.</given-names></name><name><surname>Huber</surname><given-names>W.</given-names></name><name><surname>Anders</surname><given-names>S.</given-names></name></person-group><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biol.</source><year>2014</year><volume>15</volume><fpage>550</fpage><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><?supplied-pmid 25516281?><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="B118-ijms-22-01591"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>G.R.</given-names></name><name><surname>Manduchi</surname><given-names>E.</given-names></name><name><surname>Stoeckert</surname><given-names>C.J.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Analysis and management of microarray gene expression data</article-title><source>Curr. Protoc. Mol. Biol.</source><year>2007</year><volume>77</volume><pub-id pub-id-type="doi">10.1002/0471142727.mb1906s77</pub-id><?supplied-pmid 18265395?><pub-id pub-id-type="pmid">18265395</pub-id></element-citation></ref><ref id="B119-ijms-22-01591"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cormack</surname><given-names>R.M.</given-names></name></person-group><article-title>A Review of Classification</article-title><source>J. R. Stat. Soc. Ser. A</source><year>1971</year><volume>134</volume><fpage>321</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.2307/2344237</pub-id></element-citation></ref><ref id="B120-ijms-22-01591"><label>120.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>M&#x000e4;chler</surname><given-names>M.</given-names></name><name><surname>Rousseeuw</surname><given-names>P.</given-names></name><name><surname>Struyf</surname><given-names>A.</given-names></name><name><surname>Hubert</surname><given-names>M.</given-names></name><name><surname>Hornik</surname><given-names>K.</given-names></name></person-group><source>Cluster: Cluster Analysis Basics and Extensions</source><year>2012</year><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/available_packages_by_name.html">https://cran.r-project.org/web/packages/available_packages_by_name.html</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2016-04-08">(accessed on 8 April 2016)</date-in-citation></element-citation></ref><ref id="B121-ijms-22-01591"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>V.</given-names></name><name><surname>Bell</surname><given-names>G.W.</given-names></name><name><surname>Nam</surname><given-names>J.W.</given-names></name><name><surname>Bartel</surname><given-names>D.P.</given-names></name></person-group><article-title>Predicting effective microRNA target sites in mammalian mRNAs</article-title><source>Elife</source><year>2015</year><volume>4</volume><pub-id pub-id-type="doi">10.7554/eLife.05005</pub-id><?supplied-pmid 26267216?><pub-id pub-id-type="pmid">26267216</pub-id></element-citation></ref><ref id="B122-ijms-22-01591"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schefe</surname><given-names>J.H.</given-names></name><name><surname>Lehmann</surname><given-names>K.E.</given-names></name><name><surname>Buschmann</surname><given-names>I.R.</given-names></name><name><surname>Unger</surname><given-names>T.</given-names></name><name><surname>Funke-Kaiser</surname><given-names>H.</given-names></name></person-group><article-title>Quantitative real-time RT-PCR data analysis: Current concepts and the novel &#x0201c;gene expression&#x02019;s CT difference&#x0201d; formula</article-title><source>J. Mol. Med.</source><year>2006</year><volume>84</volume><fpage>901</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1007/s00109-006-0097-6</pub-id><pub-id pub-id-type="pmid">16972087</pub-id></element-citation></ref><ref id="B123-ijms-22-01591"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leal</surname><given-names>L.G.</given-names></name><name><surname>Lopez</surname><given-names>C.</given-names></name><name><surname>Lopez-Kleine</surname><given-names>L.</given-names></name></person-group><article-title>Construction and comparison of gene co-expression networks shows complex plant immune responses</article-title><source>PeerJ</source><year>2014</year><volume>2</volume><fpage>e610</fpage><pub-id pub-id-type="doi">10.7717/peerj.610</pub-id><pub-id pub-id-type="pmid">25320678</pub-id></element-citation></ref><ref id="B124-ijms-22-01591"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Numata</surname><given-names>J.</given-names></name><name><surname>Ebenhoh</surname><given-names>O.</given-names></name><name><surname>Knapp</surname><given-names>E.W.</given-names></name></person-group><article-title>Measuring correlations in metabolomic networks with mutual information</article-title><source>Genome Inform.</source><year>2008</year><volume>20</volume><fpage>112</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">19425127</pub-id></element-citation></ref><ref id="B125-ijms-22-01591"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendes</surname><given-names>A.D.R.M.D.A.</given-names></name></person-group><article-title>Mutual information: A dependence measure for nonlinear time series</article-title><source>Econometrics</source><year>2004</year><volume>344</volume><fpage>1</fpage><lpage>358</lpage></element-citation></ref><ref id="B126-ijms-22-01591"><label>126.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Henao</surname><given-names>J.D.</given-names></name></person-group><source>Coexnet: An R Package to Build CO-EXpression NETworks from Microarray Data</source><comment>Version 1.8.0.</comment><comment>view on Bioconductor</comment><year>2019</year><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://rdrr.io/bioc/coexnet/">https://rdrr.io/bioc/coexnet/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-11-08">(accessed on 8 November 2020)</date-in-citation></element-citation></ref><ref id="B127-ijms-22-01591"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Siklenka</surname><given-names>K.</given-names></name><name><surname>Arora</surname><given-names>S.K.</given-names></name><name><surname>Ribeiro</surname><given-names>P.</given-names></name><name><surname>Kimmins</surname><given-names>S.</given-names></name><name><surname>Xia</surname><given-names>J.</given-names></name></person-group><article-title>miRNet&#x02014;Dissecting miRNA-target interactions and functional associations through network-based visual analysis</article-title><source>Nucleic Acids Res.</source><year>2016</year><volume>44</volume><fpage>W135</fpage><lpage>W141</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw288</pub-id><pub-id pub-id-type="pmid">27105848</pub-id></element-citation></ref><ref id="B128-ijms-22-01591"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Xia</surname><given-names>J.</given-names></name></person-group><article-title>miRNet-Functional Analysis and Visual Exploration of miRNA-Target Interactions in a Network Context</article-title><source>Methods Mol. Biol.</source><year>2018</year><volume>1819</volume><fpage>215</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-8618-7_10</pub-id><?supplied-pmid 30421406?><pub-id pub-id-type="pmid">30421406</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="ijms-22-01591-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Exposure to L-Tyr or 5-Brd-2&#x02032;-dU for 72 h in B16F1 cells generates a reduction in the number of cells and affects melanin concentration. (<bold>a</bold>) Representative photographs of B16F1 cells exposed to 5 mM L-Tyr or 2.5 &#x003bc;g/mL 5-Brd-2&#x02032;-dU after 72 h. (<bold>b</bold>) Quantification of the number of viable cells by Trypan Blue exclusion assay. (<bold>c</bold>) The number of cells in supernatants that incorporate Propidium Iodide (I.P.). (<bold>d</bold>) Changes in B16F1 cell number by MTT assay and population doubling times. (<bold>e</bold>) Frequency histograms of DNA content. Permeable cells incorporated PI; the cell cycle analysis corresponds to a univariate Gaussian distribution model. FlowJo algorithm function revealed phase S cells, (<bold>f</bold>) Melanin concentration from B16F1 cells after exposure to L-Tyr or 5-Brd-2&#x02032;-dU by spectrophotometry fluorescence. The significance (*) using two-tailed multiple <italic>t</italic>-tests, and the differences were considered statistically significant for a <italic>p</italic>-value &#x0003c; 0.05 using Welch&#x02019;s correction. significant (*) with <italic>p</italic> &#x0003c; 0.05, very significant (**) with <italic>p</italic> &#x0003c; 0.01, highly significant (***) with <italic>p</italic> &#x0003c; 0.001 and very highly significant (****) with <italic>p</italic> &#x0003c; 0.0001.</p></caption><graphic xlink:href="ijms-22-01591-g001"/></fig><fig id="ijms-22-01591-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>B16F1 cells exposed for 72 h to 5-Brd-2&#x02032;-dU reveal changes in markers associated with senescence. (<bold>a</bold>) Representative photographs of B16F1 cells after the chromogenic assay for senescence-associated &#x003b2;-Galactosidase activity (S.A. &#x003b2;-Gal). (<bold>b</bold>) Quantification by spectrophotometry of the S.A. &#x003b2;-Gal activity at pH 6.0. (<bold>c</bold>) Representative photographs of immunofluorescence (IF) in B16F1 cells labeled against histone H3K9me3 (green) and nucleus staining with DAPI (blue). (<bold>d</bold>) Measurement of the apparent cell area in &#x000b5;m2 from bright-field photographs of 100 B16F1 cells (<italic>n</italic> = 3). (<bold>e</bold>) Diagram of cell complexity (SSC-A) and size (FSC-A) acquired by flow cytometry and its distribution by quartiles (Q1, Q2, Q3, and Q4). The significance level (*) using two-tailed multiple <italic>t</italic>-tests, and the differences were considered statistically significant for a <italic>p</italic>-value &#x0003c; 0.05 using the Holm&#x02013;Sidak method. Significant (*) with <italic>p</italic> &#x0003c; 0.05, significant (***) with <italic>p</italic> &#x0003c; 0.001.</p></caption><graphic xlink:href="ijms-22-01591-g002"/></fig><fig id="ijms-22-01591-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>B16F1 cells induced to differential pigmentation and decreased proliferation, show changes in miRNA expression and, together with their molecular targets, make up potential gene interaction networks. (<bold>a</bold>) A heat map with the relative expression levels of 55 differentially expressed miRNAs, obtained by Small RNA-seq from B16F1 cells exposed to 5 mM L-Tyr or 2.5 &#x003bc;g.mL<sup>&#x02212;1</sup> 5-Brd-2&#x02032;-dU concerning non-exposed B16F1 control cells; red, expression up, blue, expression down, and white indicator of no variation. Differential expression by using the DESeq2 program. (<bold>b</bold>&#x02013;<bold>d</bold>) Analysis of functional enrichment by KEGG signaling pathways of the potential interactions between differentially expressed miRNAs and their molecular targets in a network model, for exposure of melanoma cells to L-Tyr (<bold>b</bold>), 5-Brd-2&#x02032;-dU (<bold>c</bold>), and 5-Brd-2&#x02032;-dU with relative to L-Tyr (<bold>d</bold>). The related KEGG signaling pathways were considered statistically significant for a <italic>p</italic>-value &#x0003c; 0.05 after applying a hypergeometric test.</p></caption><graphic xlink:href="ijms-22-01591-g003"/></fig><fig id="ijms-22-01591-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Sets of miRNAs show coordinated expression patterns in the differential pigmentation model and reduced proliferation induced in melanoma B16F1 cells. Sets of over-and under-expressed miRNAs and their potential candidate genes associated with cell cycle and senescence control (<bold>a</bold>) and melanogenesis (<bold>b</bold>) using the TargetScanMouse tool version 7.1. (<bold>c</bold>) Relative expression radius (rER) of miRNAs by RT-qPCR stem-loop for miRNAs 211-5p, 148b-3p, 470-5p, 129-5p, 27b-3p, 470-3p and 30d-5p (<italic>n</italic> = 3). (<bold>d</bold>) Co-expression networks from normalized Small RNA-Seq count of under-expressed miRNAs of B16F1 cells exposed to L-Tyr or 5-Brd-2&#x02032;-dU. The level of significance (*) using two-tailed multiple <italic>t</italic>-tests. The differences were considered statistically significant for a <italic>p</italic>-value &#x0003c; 0.05, ns: not significant. Significant (*) with <italic>p</italic> &#x0003c; 0.05, very significant (**) with <italic>p</italic> &#x0003c; 0.01, highly significant (***) with <italic>p</italic> &#x0003c; 0.001.</p></caption><graphic xlink:href="ijms-22-01591-g004"/></fig><fig id="ijms-22-01591-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Variations in the expression of genes and their protein products, associated with controlling the cell cycle and senescence in B16F1 cells, induced differential pigmentation and decreased proliferation. Relative expression radius (rER) by RT-qPCR, (<italic>n</italic> = 4), representative photographs of the location and distribution by immunofluorescence (red) in nuclear counterstain with DAPI (blue), quantification of expression by mean fluorescence intensity (MFI), and western blot for CCnd1 (<bold>a</bold>&#x02013;<bold>c</bold>), Cdk4 (<bold>d</bold>&#x02013;<bold>f</bold>), Cdk2 (<bold>g</bold>&#x02013;<bold>i</bold>) and p21 (<bold>j</bold>&#x02013;<bold>m</bold>). The level of significance (*) using two-tailed multiple <italic>t</italic>-tests. The differences were considered statistically significant for a <italic>p</italic>-value &#x0003c; 0.05, ns: not significant. Significant (*) with <italic>p</italic> &#x0003c; 0.05, very significant (**) with <italic>p</italic> &#x0003c; 0.01, highly significant (***) with <italic>p</italic> &#x0003c; 0.001.</p></caption><graphic xlink:href="ijms-22-01591-g005"/></fig><fig id="ijms-22-01591-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Variations in the expression of genes and their protein products are associated with melanogenesis in B16F1 cells induced at differential pigmentation and a decrease in proliferation. Relative expression radius (rER) by RT-qPCR, <italic>n</italic> = 4, representative photographs of the location and distribution by immunofluorescence (red) in nuclear counterstain with DAPI (blue), quantification of expression by mean fluorescence intensity (MFI), and western blot for the master regulator of melanocyte cell differentiation&#x02014;MITF (<bold>a</bold>&#x02013;<bold>c</bold>), and the enzymes Tyr (<bold>d</bold>&#x02013;<bold>f</bold>), Trp1 (<bold>g</bold>&#x02013;<bold>i</bold>), and Dct (<bold>j</bold>&#x02013;<bold>l</bold>). The level of significance (*) using two-tailed multiple <italic>t</italic>-tests. The differences were considered statistically significant for a <italic>p</italic>-value &#x0003c; 0.05, ns: not significant. Significant (*) with <italic>p</italic> &#x0003c; 0.05, very significant (**) with <italic>p</italic> &#x0003c; 0.01, highly significant (***) with <italic>p</italic> &#x0003c; 0.001 and very highly significant (****) with <italic>p</italic> &#x0003c; 0.0001.</p></caption><graphic xlink:href="ijms-22-01591-g006"/></fig><table-wrap id="ijms-22-01591-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-22-01591-t001_Table 1</object-id><label>Table 1</label><caption><p>List of differential microRNAs expression in B16F1 melanoma cells exposed for 72 h to 5-Bromo-2-Deoxyuridine 2.5 &#x000b5;g.mL<sup>&#x02212;1</sup> or L-Tyrosine amino acid 5 mM. microRNA ID refers to the identification number of miRNA register in miRBase; Log2 Fold Change represents times of change in the expression; <italic>p</italic>-value corresponds to the statistical significance and p-<italic>adj</italic> significance by multiple tests correction; baseMean means the average counts.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">L-Tyr vs. Respect to Unexposed B16 Cells</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">5-Brd-2&#x02032;-dU vs. Respect to Unexposed B16 cells</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">5-Brd-2&#x02032;-dU vs. Respect to L-Tyr</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">microRNA ID</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">log<sub>2</sub> Fold Change</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>p</italic>
<sub>Value</sub>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p<italic><sub>adj</sub></italic></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BaseMean</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">microRNA ID</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">log<sub>2</sub> Fold Change</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>p</italic>
<sub>Value</sub>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p<italic><sub>adj</sub></italic></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BaseMean</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">microRNA ID</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">log<sub>2</sub> Fold Change</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>p</italic>
<sub>Value</sub>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p<italic><sub>adj</sub></italic></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BaseMean</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-let-7d-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.93</td><td align="center" valign="middle" rowspan="1" colspan="1">8.701 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.504 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2014</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-3963</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.85</td><td align="center" valign="middle" rowspan="1" colspan="1">1804 &#x000d7; 10<sup>&#x02212;9</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.401 &#x000d7; 10<sup>&#x02212;6</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">29645</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-30d-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.04</td><td align="center" valign="middle" rowspan="1" colspan="1">8.70 &#x000d7; 10<sup>&#x02212;6</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">6.50 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2326</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-let-7a-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.64</td><td align="center" valign="middle" rowspan="1" colspan="1">1.05 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.27 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1648</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-let-7a-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.96</td><td align="center" valign="middle" rowspan="1" colspan="1">6.47 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.093 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1300</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-211-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.20</td><td align="center" valign="middle" rowspan="1" colspan="1">1.03 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7.15&#x000d7;10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2024</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-151-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.94</td><td align="center" valign="middle" rowspan="1" colspan="1">3.567 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.375 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">859</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-let-7d-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.89</td><td align="center" valign="middle" rowspan="1" colspan="1">1.425 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.882 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1030</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-1249-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.23</td><td align="center" valign="middle" rowspan="1" colspan="1">6.09 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.02 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">705</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-29a-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.94</td><td align="center" valign="middle" rowspan="1" colspan="1">2.239 &#x000d7; 10<sup>&#x02212;7</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.885 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">636</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-211-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.36</td><td align="center" valign="middle" rowspan="1" colspan="1">3.164 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.199 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">696</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-211-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.87</td><td align="center" valign="middle" rowspan="1" colspan="1">1.16 &#x000d7; 10<sup>&#x02212;6</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.89 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">126</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-let-7c-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.84</td><td align="center" valign="middle" rowspan="1" colspan="1">1.247 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.762 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">533</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-128-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.91</td><td align="center" valign="middle" rowspan="1" colspan="1">9.496 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">4.589 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">232</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-30a-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.10</td><td align="center" valign="middle" rowspan="1" colspan="1">5.56 &#x000d7; 10<sup>&#x02212;9</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.70 &#x000d7; 10<sup>&#x02212;6</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">45</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-27b-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.47</td><td align="center" valign="middle" rowspan="1" colspan="1">5.270 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.97 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">377</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-361-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.72</td><td align="center" valign="middle" rowspan="1" colspan="1">8.53 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">4.014 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">204</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-501-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.40</td><td align="center" valign="middle" rowspan="1" colspan="1">1.38 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">6.27 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">43</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-148b-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.00</td><td align="center" valign="middle" rowspan="1" colspan="1">2.046 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.775 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">118</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-138-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.26</td><td align="center" valign="middle" rowspan="1" colspan="1">1.889 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.000 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">65</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-130b-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.16</td><td align="center" valign="middle" rowspan="1" colspan="1">5.74 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.15 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">31</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-23a-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.05</td><td align="center" valign="middle" rowspan="1" colspan="1">1.413 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7.519&#x000d7;10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">49</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-671-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.35</td><td align="center" valign="middle" rowspan="1" colspan="1">1.686 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">4.292 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">27</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-671-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.76</td><td align="center" valign="middle" rowspan="1" colspan="1">1.30 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">6.12 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">29</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-99b-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.98</td><td align="center" valign="middle" rowspan="1" colspan="1">3.64 &#x000d7; 10<sup>&#x02212;7</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">5.535 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">45</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-30a-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.20</td><td align="center" valign="middle" rowspan="1" colspan="1">1.719 &#x000d7; 10<sup>&#x02212;6</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.670 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">26</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-351-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.35</td><td align="center" valign="middle" rowspan="1" colspan="1">9.37 &#x000d7; 10<sup>&#x02212;6</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">9.10 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">25</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-let-7g-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.44</td><td align="center" valign="middle" rowspan="1" colspan="1">8.90 &#x000d7; 10<sup>&#x02212;9</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">4.118 &#x000d7; 10<sup>&#x02212;6</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">45</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-23a-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.13</td><td align="center" valign="middle" rowspan="1" colspan="1">8.000 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.484 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">17</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-6236</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.22</td><td align="center" valign="middle" rowspan="1" colspan="1">1.52 &#x000d7; 10<sup>&#x02212;6</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.02 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">22</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-30c-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.09</td><td align="center" valign="middle" rowspan="1" colspan="1">6.679 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.377 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">35</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-532-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.10</td><td align="center" valign="middle" rowspan="1" colspan="1">1.498 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.976 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">11</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-103-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.20</td><td align="center" valign="middle" rowspan="1" colspan="1">1.32 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">4.38 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">11</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-103-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.87</td><td align="center" valign="middle" rowspan="1" colspan="1">5.338 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">4.116 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">32</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-99b-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">1.14</td><td align="center" valign="middle" rowspan="1" colspan="1">2.312 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7.241 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">10602</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-26a-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">0.73</td><td align="center" valign="middle" rowspan="1" colspan="1">6.91 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.63 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1879</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-23b-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.70</td><td align="center" valign="middle" rowspan="1" colspan="1">1.346 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7.473 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">28</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-129-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">1.6</td><td align="center" valign="middle" rowspan="1" colspan="1">2.962 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.550 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1955</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-21a-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">1.67</td><td align="center" valign="middle" rowspan="1" colspan="1">6.68 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.02 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">518</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-361-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.39</td><td align="center" valign="middle" rowspan="1" colspan="1">1.787 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">8.670 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">23</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-22-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">1.32</td><td align="center" valign="middle" rowspan="1" colspan="1">1.698 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">6.194 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">764</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-let-7b-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">1.78</td><td align="center" valign="middle" rowspan="1" colspan="1">9.39 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">4.57 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">203</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-31-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.01</td><td align="center" valign="middle" rowspan="1" colspan="1">1.881 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">8.704 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">22</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-30d-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">1.20</td><td align="center" valign="middle" rowspan="1" colspan="1">2.214 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.719 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">618</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-335-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">4.00</td><td align="center" valign="middle" rowspan="1" colspan="1">3.35 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.14 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">141</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-101b-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.12</td><td align="center" valign="middle" rowspan="1" colspan="1">3.302 &#x000d7; 10<sup>&#x02212;6</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.554 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">17</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-191-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">1.48</td><td align="center" valign="middle" rowspan="1" colspan="1">3.663 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.326 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">574</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-193b-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">6.14</td><td align="center" valign="middle" rowspan="1" colspan="1">1.23 &#x000d7; 10<sup>&#x02212;14</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">8.95 &#x000d7; 10<sup>&#x02212;12</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">68</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-320-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.37</td><td align="center" valign="middle" rowspan="1" colspan="1">1.658 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">8.670 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">14</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-21a-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">2.17</td><td align="center" valign="middle" rowspan="1" colspan="1">2.679 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7.450 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">560</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-484</td><td align="center" valign="middle" rowspan="1" colspan="1">2.88</td><td align="center" valign="middle" rowspan="1" colspan="1">1.89 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.44 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">65</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-181b-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.11</td><td align="center" valign="middle" rowspan="1" colspan="1">7.574 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.564 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-335-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">3.32</td><td align="center" valign="middle" rowspan="1" colspan="1">1.029 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.727 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">329</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-99b-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">2.89</td><td align="center" valign="middle" rowspan="1" colspan="1">3.87 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.52 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">54</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-872-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.37</td><td align="center" valign="middle" rowspan="1" colspan="1">2.226 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">9.848 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-let-7b-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">1.77</td><td align="center" valign="middle" rowspan="1" colspan="1">1.009 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.909 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">228</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-335-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">4.75</td><td align="center" valign="middle" rowspan="1" colspan="1">1.05 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">6.80 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">51</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-29a-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.51</td><td align="center" valign="middle" rowspan="1" colspan="1">1.083 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">6.592 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">11</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-129-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">2.10</td><td align="center" valign="middle" rowspan="1" colspan="1">2.947 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.149 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">191</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-365-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">4.30</td><td align="center" valign="middle" rowspan="1" colspan="1">9.47 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7.20 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">42</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-339-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.15</td><td align="center" valign="middle" rowspan="1" colspan="1">6.087 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.283 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">11</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-335-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">3.46</td><td align="center" valign="middle" rowspan="1" colspan="1">4.762 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.917 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">171</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-miR-144-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">3.54</td><td align="center" valign="middle" rowspan="1" colspan="1">4.52 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.74 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">35</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-93-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.84</td><td align="center" valign="middle" rowspan="1" colspan="1">1.31 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.868 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-455-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">2.75</td><td align="center" valign="middle" rowspan="1" colspan="1">2.150 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7.299 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">153</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-27b-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">3.46</td><td align="center" valign="middle" rowspan="1" colspan="1">6.08 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.17 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">32</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-30d-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">1.02</td><td align="center" valign="middle" rowspan="1" colspan="1">8.078 &#x000d7; 10<sup>&#x02212;6</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7.626 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">5118</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-378a-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">2.07</td><td align="center" valign="middle" rowspan="1" colspan="1">5.965 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.431 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">104</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-320-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">3.65</td><td align="center" valign="middle" rowspan="1" colspan="1">2.18 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">9.65 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">23</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-211-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">1.1</td><td align="center" valign="middle" rowspan="1" colspan="1">6.743 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.318 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1391</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-193b-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">3.64</td><td align="center" valign="middle" rowspan="1" colspan="1">1.059 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">4.269 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">97</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-27a</td><td align="center" valign="middle" rowspan="1" colspan="1">4.21</td><td align="center" valign="middle" rowspan="1" colspan="1">1.61 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.38 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">21</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-211-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">1.26</td><td align="center" valign="middle" rowspan="1" colspan="1">8.183 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">5.408 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">159</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-miR-144-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">3.79</td><td align="center" valign="middle" rowspan="1" colspan="1">9.074 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">4.145 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">42</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-193b</td><td align="center" valign="middle" rowspan="1" colspan="1">4.03</td><td align="center" valign="middle" rowspan="1" colspan="1">4.33 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.52 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">20</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-129-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">1.35</td><td align="center" valign="middle" rowspan="1" colspan="1">4.746 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.553 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">677</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-29c-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">3.42</td><td align="center" valign="middle" rowspan="1" colspan="1">2.991 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.161 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">23</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-221-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">3.39</td><td align="center" valign="middle" rowspan="1" colspan="1">7.87 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.80 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">15</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-99b-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">0.85</td><td align="center" valign="middle" rowspan="1" colspan="1">2.270 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">9.848 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">670</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-365-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">3.64</td><td align="center" valign="middle" rowspan="1" colspan="1">7.318 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.788 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">22</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-let-7e-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">3.66</td><td align="center" valign="middle" rowspan="1" colspan="1">2.37 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.02 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">13</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-1249-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">2.11</td><td align="center" valign="middle" rowspan="1" colspan="1">6.548 &#x000d7; 10<sup>&#x02212;8</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.515 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">524</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-26a-2-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">3.03</td><td align="center" valign="middle" rowspan="1" colspan="1">1.511 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.976 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">22</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-455-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">3.36</td><td align="center" valign="middle" rowspan="1" colspan="1">8.42 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.90 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">12</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-191-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1">3.067 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.228 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">355</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-let-7e-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">3.35</td><td align="center" valign="middle" rowspan="1" colspan="1">4.058 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.500 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-129-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">2.10</td><td align="center" valign="middle" rowspan="1" colspan="1">3.328 &#x000d7; 10<sup>&#x02212;6</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.554 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">322</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-328-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">4.18</td><td align="center" valign="middle" rowspan="1" colspan="1">8.692 &#x000d7; 10<sup>&#x02212;6</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.038 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">16</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-328-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">2.50</td><td align="center" valign="middle" rowspan="1" colspan="1">6.864 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">5.014 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">81</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-542-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">3.37</td><td align="center" valign="middle" rowspan="1" colspan="1">5.392 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.820 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">16</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-151-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">2.38</td><td align="center" valign="middle" rowspan="1" colspan="1">1.237 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7.153 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">61</td><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-23b-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">3.13</td><td align="center" valign="middle" rowspan="1" colspan="1">1.360 &#x000d7; 10<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.770 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-143-3p</td><td align="center" valign="middle" rowspan="1" colspan="1">4.01</td><td align="center" valign="middle" rowspan="1" colspan="1">6.562 &#x000d7; 10<sup>&#x02212;7</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">8.280 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-149-5p</td><td align="center" valign="middle" rowspan="1" colspan="1">3.03</td><td align="center" valign="middle" rowspan="1" colspan="1">9.253 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.987 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">26</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mmu-mir-6236</td><td align="center" valign="middle" rowspan="1" colspan="1">4.38</td><td align="center" valign="middle" rowspan="1" colspan="1">1.794 &#x000d7; 10<sup>&#x02212;7</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.556 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">21</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">mmu-mir-423-3p</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.79</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.246 &#x000d7; 10<sup>&#x02212;</sup><sup>3</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.762 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table></table-wrap></floats-group></article>